Profile Image

Staff Profile

Edit

Career Summary

Biography

Professor Paul Foster is the Director of the Priority Research Centre for Asthma and Respiratory Disease; the Virus, Infection/Immunity, Vaccines and Asthma Program, Hunter Medical Research Institute and the Cooperative Research Centre (CRC) for Asthma and Airways (Newcastle node). He also currently holds the Chair of Immunology, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle. He is also a visiting Professor at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. He serves as an Associate Editor of the American Journal of Respiratory Cell and Molecular Biology and the Journal of Pharmacology and Therapeutics, and is on the Editorial Boards of a number of leading international immunology/allergy journals. Professor Foster's research focuses on understanding the molecular and cellular basis of asthma, allergy, respiratory disorders, and chronic inflammation. His research program focuses on translational approaches directed towards the development of novel anti-inflammatory therapies. Professor Foster's research findings are published in the most highly ranked medical and biomedical science journals (e.g. Nature Immunology and Journal of Experimental Medicine). Essential Science Indicators metrics places his team on the forefront of his field internationally. Professor Foster receives numerous and ongoing invitations to speak and chair sessions and leading international conferences in immunology and respiratory medicine (e.g. American Academy of Asthma, Allergy and Immunology, Keystone, Cold Spring Harbor, International Congress on Immunology and International Eosinophil meeting). The importance of his team's work has been recognised through award of over $10.5 million in direct funding (since 2003) through Australian national competitive grants.

Since 1995 Professor Foster's laboratory has focused on the biology of T cells and granulocytes, and on signaling by cytokines and chemokines pertinent to regulating allergic inflammatory responses, in particular asthma. In the last 5 years we have extended our focus to understanding the relationship between inflammation induced by infection (viruses, bacteria and microbial products), at various times through life, on the subsequent development of the T cell repertoire and on chronic inflammation in the lung. A focus on the role of microRNAs in the regulation of inflammation is also a main focus.

Professor Foster's activities have been supported through grants from the NHMRC (program and project grants), Australian Research Council (Discovery and LIEF grants), Human Frontiers Science Foundation, and through the CRC for Asthma and Airways. Professor Foster actively contributes to peer review at a national and international level (e.g. NHMRC; fellowship, program and project reviews/grant panel; Wellcome Trust; and leading international journals (e.g. J. of Clin. Invest., J. of Exp. Med., and Nature).

Professor Foster is also on the Editorial Board of:

• American Journal of Respiratory Cell & Molecular Biology

• Pharmacology & Therapeutics (Associate Editor)

• Current Molecular Medicine

• Journal Inflammation and Allergy

• Clinical and Experimental Allergy

Qualifications

  • PhD, Australian National University, 15/04/1988
  • Bachelor of Science (Honours), University of Western Australia

Research

Research keywords

  • Allergy
  • Asthma
  • Chronic Inflammation
  • Immunology
  • Leukocyte Biology

Research expertise

Current research in my laboratory primarily aims at defining the key cellular and molecular processes that underlie the development of allergic disease (lung, skin and gastrointestinal tract) and of viral (RSV and influenza) induced pulmonary inflammation. We are particularly interested in the molecular events that predispose to remodeling of the airways in chronic disease and the subsequent impact on lung function. In particular, projects are focusing on the biology of CD4+ Th2 cells, CD8+ T cells and eosinophils, and in signaling arrangements between cytokine and chemokine systems that pertain to allergic disease, viral induced pathogenesis and viral induced exacerbation of asthma. Our aim is to develop integrative concepts on molecular mechanisms of pathogenesis by employing an approach that is multifactorial ranging from transgenic systems to the identification of novel gene products. The laboratory has established in vivo models of asthma (acute and chronic), allergic cutaneous disease and of eosinophil and lymphocyte homing to sites of allergen or viral provocation. Models of RSV infection in the presence and absence of allergic inflammation are also established. These models, in conjunction with mice that are factor deficient or transgenic (constitutive and inducible systems that are airway specific, and T cell transgenic systems), are currently being employed to define the individual role of inflammatory cells and cytokines/chemokines in the pathophysiology of allergic and viral disorders and viral induced exacerbation of allergic inflammation. Collectively, this approach is providing a fundamental platform for the identification of key targets for potential therapeutic intervention in these diseased states and models for the development of novel anti-inflammatory approaches. Models of leukocyte trafficking and pathogenesis are combined with experimental programs at a cellular level to enhance the understanding of the molecular basis of disease. Novel mechanisms to attenuate allergic and viral induced disease are also being explored. We have also established models of chronic obstructive pulmonary disease (COPD).

Current PhD and Honours projects within my team aim to gather an understanding in:

• the role of miRNA in asthma and infection

• the role of viruses in inducing asthma and COPD

• miRNA regulation of leukocyte differentiation

• the innate immune system in severe asthma

Fields of Research

CodeDescriptionPercentage
110799Immunology Not Elsewhere Classified75
110200Cardiovascular Medicine And Haematology25

Memberships

ARC Committee member

  • Member

Committee/Associations (relevant to research).

  • Member - CRC for Asthma and Airways
  • Editor - (Small Granting Agencies State Foundations and Councils)
  • member - American Society for Immunology
  • member - International Eosinophil Society
  • member - International Mucosal Immunology Society
  • member - The Australian Lung foundation
  • member - The Australian Society for Immunolgy
  • member - The Thoracic Society of Australia and New Zealand

Editorial Board.

  • Editor - Journal Inflammation and Allergy
  • Editor - Clinical and Experimental Allergy
  • Editor - American Journal of Respiratory Cell and Molecular Biology
  • Associate Editor - Pharmacology & Therapeutics

Appointments

Visiting Professorship
Harvard University, MA (United States)
01/01/2010

Awards

Research Award.

2010Research Excellence
HMRI (Australia)
1999Australian Academy of Science and The Royal Society Travelling Fellowship
ANU (Australia)
1997Human Frontiers Science Programme International Collaborative Grant
ANU (Australia)
1996The British council Collaborative Research Award
ANU (Australia)
1996The John curtin School of Medical Research, Howard Florey Young Investigators Award
ANU (Australia)
1996The Asthma foundation of NSW, The Jean Jeavons grant for Asthma Research
ANU (Australia)
1994Australian Academy of Science and The Royal Society Travelling Fellowship
ANU (Australia)
1983Commonwealth Postgraduate Research Scholarship
ANU (Australia)

Research Funding

2005CRC for Asthma and Airways
University of Newcastle (Australia)
2003NHMRC Programme Grant 2003-2007
ANU (Australia)

Invitations

Congress of the European Academy of Allergy and Clinical Immunology
29th Conference, United Kingdom (Invited Speaker)
2010
The American Academy of Asthma, Allergy and Immunology (AAAAI)
65th Annual Meeting - Mini-symposium (educational section), United States (Invited Speaker)
2010
Biennial Symposium International Eosinophil Society
6th Conference, Belgium (Invited Speaker)
2009
The American Academy of Asthma, Allergy and Immunology (AAAAI)
64th Annual Meeting - Mini-symposium (educational section), United States (Invited Speaker)
2009
The American Academy of Asthma, Allergy and Immunology (AAAAI)
63nd Annual Meeting - Mini-symposium (educational section)., United States (Invited Speaker)
2008
Molecular Therapeutics of Cancer
Gordon Conference, United States (Invited Speaker)
2007
Biennial Symposium International Eosinophil Society
5th Conference, United States (Invited Speaker)
2007
International Congress of Immunology
14th Conference, Brazil (Invited Speaker)
2007
The American Academy of Asthma, Allergy and Immunology (AAAAI)
61st Annual Meeting - Mini-symposium (educational section), United States (Invited Speaker)
2006
The American Academy of Asthma, Allergy and Immunology (AAAAI)
60th Annual Meeting - Symposium Chemokines and Receptors, United States (Invited Speaker)
2005
25th International Symposium
Collegium Internationalale Allergologicum, Sweden (Invited speaker)
2004
12th International Congress on Immunology
4th Annual Conerence of FOCIS, Canada (Invited speaker)
2004

Collaboration

I have extensive national and international collaborations and associations with leading investigators and biotechnology and pharmaceutical companies. For example:

• Professor Andrew Mackenzie, Laboratory of Molecular Biology, Cambridge University, UK.

• Professor K Takeda and S Akira, Osaka University, Osaka Japan.

• Professor Marc Rothenberg, Children’s Hospital Medical Centre, Cincinnati, OH.

• Professor Helene Rosenberg, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.

• Professor Richard Stevens, Harvard Medical School, Boston MA.

• Professor Sebastian Johnston, Imperial College, London UK.

• Professor Pardric Fallon, Trinity College, Dublin, Ireland.

• GSK.

• MedImmune Inc, Washington DC, USA.

• Commonwealth Serum Laboratories, Parkville, Melbourne, Australia.

Administrative

Administrative expertise

• Hunter Medical Research Institute Building Committee

• Research Committee - Member

• Academic Senate - Member

• Animal Services Research Facility, Advisory Committee, Sub-committee - Member

• Analytical and Biomolecular Research Facility Advisory

• Strategic Research Advisory Panel HMRI - Member

• Research Committee, School of Biomedical Sciences and Pharmacy, University of Newcastle - Member

• Steering Committee, Vaccines, Infection, Virus and Asthma Group, HMRI - Member

Teaching

Teaching keywords

  • Biomedical Sciences
  • Immunology
  • Medicine
  • Pharmacy

Teaching expertise

• Immunology

• Research Commercialisation

Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2006Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmmermann N, Mahalingam S, et al., 'Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness', Journal of Immunology, 177 5595-5603 (2006) [C1]

Co-authors: Ming Yang

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Chapter (6 outputs)

YearCitationAltmetricsLink
2013Lee JJ, Ptaschinski C, Plank M, Mattes J, Foster PS, Balla KM, et al., 'Emerging Concepts', Eosinophils in Health and Disease, Academic Press, London 607-641 (2013) [B1]
2008Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al., 'Eosinophils: Biological properties and role in health and allergic diseases', Allergy and Allergic Diseases, Wiley-Blackwell, Hoboken 258-294 (2008) [B1]
2004Kumar RL, Foster PS, 'Lessons from a model of chronic asthma', Focus on Asthma, Nova Science Publishers, New York, United States 165-183 (2004) [B1]
2000Simson L, Foster PS, 'Chemokine and Cytokine Cooperativity', Chemokines in Allergic Disease, Marcel Dekker, New York, USA 289-309 (2000) [B1]
1999Foster PS, Hogan S, Matthaei K, Young I, 'The role of interleukin-5 in allergic airways disease.', Interleukin-5, Marcel Dekker, New York, USA 127-135 (1999) [B1]
1999Ramsay A, Hogan S, Foster PS, Xiong Y, 'Gene therapy of allergic airways inflammation', Progress in Inflammation Research: Gene Therapy of Inflammatory Diseases, Birkhauser Publishing, Basel, Switzerland 65-72 (1999) [B1]
Show 3 more

Journal article (203 outputs)

YearCitationAltmetricsLink
2014Kumar RK, Foster PS, Rosenberg HF, 'Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.', J Leukoc Biol, 96 391-396 (2014)
2014Collison A, Li J, Pereira de Siqueira A, Zhang J, Toop HD, Morris JC, et al., 'Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease.', Am J Respir Cell Mol Biol, 51 86-93 (2014)
2014Xiang Y, Eyers F, Young IG, Rosenberg HF, Foster PS, Yang M, 'Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells.', PLoS One, 9 e98139 (2014)
2014Hatchwell L, Girkin J, Morten M, Collison A, Mattes J, Foster PS, et al., 'Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A', Journal of Allergy and Clinical Immunology, 133 1720-1727 (2014)
2014Maltby S, Hansbro NG, Tay HL, Stewart J, Plank M, Donges B, et al., 'Production and Differentiation of Myeloid Cells Driven by Proinflammatory Cytokines in Response to Acute Pneumovirus Infection in Mice.', J Immunol, (2014)
2014Starkey MR, Nguyen DH, Essilfie AT, Kim RY, Hatchwell LM, Collison AM, et al., 'Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.', Mucosal Immunol, 7 478-488 (2014)
2014Hansbro PM, Hamilton MJ, Fricker M, Gellatly SL, Jarnicki AG, Zheng D, et al., 'Importance of mast cell Prss31/transmembrane tryptase/tryptase-¿ in lung function and experimental chronic obstructive pulmonary disease and colitis.', J Biol Chem, 289 18214-18227 (2014)
2014Yang M, Eyers F, Xiang Y, Guo M, Young IG, Rosenberg HF, Foster PS, 'Expression profiling of differentiating eosinophils in bone marrow cultures predicts functional links between microRNAs and their target mRNAs.', PLoS One, 9 e97537 (2014)
2013Rosenberg HF, Dyer KD, Foster PS, 'Eosinophils: changing perspectives in health and disease', NATURE REVIEWS IMMUNOLOGY, 13 9-22 (2013) [C1]
2013Li JJ, Tay HL, Plank M, Essilfie A-T, Hansbro PM, Foster PS, Yang M, 'Activation of Olfactory Receptors on Mouse Pulmonary Macrophages Promotes Monocyte Chemotactic Protein-1 Production', PLOS ONE, 8 (2013) [C1]
2013Thorburn AN, Brown AC, Nair PM, Chevalier N, Foster PS, Gibson PG, Hansbro PM, 'Pneumococcal Components Induce Regulatory T Cells That Attenuate the Development of Allergic Airways Disease by Deviating and Suppressing the Immune Response to Allergen', JOURNAL OF IMMUNOLOGY, 191 4112-4120 (2013) [C1]
2013Barry J, Loh Z, Collison A, Mazzone S, Lalwani A, Zhang V, et al., 'Absence of Toll-IL-1 Receptor 8/Single Immunoglobulin IL-1 Receptor-Related Molecule Reduces House Dust Mite-Induced Allergic Airway Inflammation in Mice', AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 49 481-490 (2013) [C1]
2013de Souza Alves CC, Collison A, Hatchwell L, Plank M, Morten M, Foster PS, et al., 'Inhibiting AKT phosphorylation employing non-cytotoxic anthraquinones ameliorates TH2 mediated allergic airways disease and rhinovirus exacerbation.', PLoS One, 8 e79565 (2013) [C1]
2013Collison A, Siegle JS, Hansbro NG, Kwok C-T, Herbert C, Mattes J, et al., 'Epigenetic changes associated with disease progression in a mouse model of childhood allergic asthma', DISEASE MODELS & MECHANISMS, 6 993-1000 (2013) [C1]
2013Beckett EL, Stevens RL, Jarnicki AG, Kim RY, Hanish I, Hansbro NG, et al., 'A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis', The Journal of Allergy and Clinical Immunology, 131 752-762 (2013) [C1]
2013Collison AM, Hatchwell LM, Verrills NM, Wark PA, Pereira De Siqueira AL, Tooze MK, et al., 'The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity', Nature Medicine, 19 232-237 (2013) [C1]
2013Herbert C, Siegle JS, Shadie AM, Nikolaysen S, Garthwaite L, Hansbro NG, et al., 'Development of asthmatic inflammation in mice following early-life exposure to ambient environmental particulates and chronic allergen challenge', DMM Disease Models and Mechanisms, 6 479-488 (2013) [C1]

Co-authors: Nicole Hansbro

2013Plank M, Maltby S, Foster PS, Mattes J, 'Targeting translational control as a novel way to treat inflammatory disease: The emerging role of MicroRNAs', Clinical and Experimental Allergy, 43 981-999 (2013) [C1]
2013Starkey MR, Jarnicki AG, Essilfie A-T, Gellatly SL, Kim RY, Brown AC, et al., 'Murine models of infectious exacerbations of airway inflammation', CURRENT OPINION IN PHARMACOLOGY, 13 337-344 (2013) [C1]
2013Kaiko GE, Loh Z, Spann K, Lynch JP, Lalwani A, Zheng Z, et al., 'Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 131 1331-U132 (2013) [C1]
2013Hansbro PM, Scott GV, Essilfie A-T, Kim RY, Starkey MR, Nguyen D, et al., 'Th2 cytokine antagonists: Potential treatments for severe asthma', Expert Opinion on Investigational Drugs, 22 49-69 (2013) [C1]
2013Eftekhari P, Hajizadeh S, Reza Raoufy M, Reza Masjedi M, Yang M, Hansbro N, et al., 'Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma', EXCLI Journal, 12 184-192 (2013) [C1]
2013Foster PS, Plank MW, Collison AM, Tay HL, Kaiko GE, Li J, et al., 'The emerging role of microRNAs in regulating immune and inflammatory responses in the lung', Immunological Reviews, 253 198-215 (2013) [C1]
2013Plank M, Maltby S, Mattes J, Foster PS, 'Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs.', Clinical and Experimental Allergy, 43 981-999 (2013) [C1]
2013Starkey MR, Essilfie A-T, Horvat JC, Kim RY, Nguyen DH, Beagley KW, et al., 'Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease', Mucosal Immunology, 6 569-579 (2013) [C1]
2013Rosenberg HF, Foster PS, 'Eosinophil cytolysis and release of cell-free granules', NATURE REVIEWS IMMUNOLOGY, 13 (2013) [C3]
2012Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Components of streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells', The Journal of Immunology, 188 4611-4620 (2012) [C1]
2012Hansbro PM, Starkey MR, Kim RY, Stevens RL, Foster PS, Horvat JC, 'Programming of the lung by early-life infection', Journal of Developmental Origins of Health and Disease, 3 153-158 (2012) [C1]
2012Kumar RK, Foster PS, 'Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness?', Frontiers in Physiology, 3 1-7 (2012) [C1]
2012Beckett EL, Phipps S, Starkey MR, Horvat JC, Beagley KW, Foster PS, Hansbro PM, 'TLR2, but not TLR4, is required for effective host defence against chlamydia respiratory tract infection in early life', PLOS One, 7 e39460 (2012) [C1]
2012Essilfie A-T, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, Gibson PG, et al., 'Combined haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma', Thorax, 67 588-599 (2012) [C1]
2012Yang M, Kumar RK, Hansbro PM, Foster PS, 'Emerging roles of pulmonary macrophages in driving the development of severe asthma', Journal of Leukocyte Biology, 91 557-569 (2012) [C1]
2012Kumar RK, Yang M, Herbert C, Foster PS, 'Interferon-¿, pulmonary macrophages and airway responsiveness in asthma', Inflammation and Allergy - Drug Targets, 11 292-297 (2012) [C1]

Co-authors: Ming Yang

2012Munitz A, Foster PS, 'T(H)9 cells: In front and beyond T(H)2', Journal of Allergy and Clinical Immunology, 129 1011-1013 (2012) [C3]
2011Siegle JS, Hansbro NG, Dong C, Angkasekwinai P, Foster PS, Kumar RK, 'Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma', Clinical and Experimental Immunology, 165 19-28 (2011) [C1]
2011Wang W, Hansbro PM, Foster PS, Yang M, 'An alternate STAT6-independent pathway promotes eosinophil influx into blood during allergic airway inflammation', PLoS ONE, 6 e17766 (2011) [C1]
2011Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, Wade MA, et al., 'Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells', European Respiratory Journal, 37 53-64 (2011) [C1]
2011Lousberg EL, Diener KR, Fraser CK, Phipps S, Foster PS, Chen W, et al., 'Antigen-specific T-Cell responses to a recombinant fowlpox virus are dependent on MyD88 and Interleukin-18 and Independent of Toll-Like Receptor 7 (TLR7)- and TLR9-Mediated innate immune recognition', Journal of Virology, 85 3385-3396 (2011) [C1]
2011Kaiko GE, Foster PS, 'New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma', Current Opinion in Allergy and Clinical Immunology, 11 39-45 (2011) [C1]
2011Collison AM, Mattes J, Plank MW, Foster PS, 'Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment', Journal of Allergy and Clinical Immunology, 128 160-U251 (2011) [C1]

Co-authors: Joerg Mattes

2011Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, Hansbro PM, Foster PS, 'Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts', PLoS Pathogens, 7 e1001339 (2011) [C1]
2011Collison AM, Herbert C, Siegle JS, Mattes J, Foster PS, Kumar RK, 'Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target', BMC Pulmonary Medicine, 11 29 (2011) [C1]

Co-authors: Joerg Mattes

2011Davidson SK, Kaiko GE, Loh Z, Lalwani A, Zhang V, Spann K, et al., 'Plasmacytoid Dendritic Cells promote host defense against Acute Pneumovirus infection via the TLR7-MyD88-Dependent signaling pathway', Journal of Immunology, 186 5938-5948 (2011) [C1]
2011Essilfie A-T, Simpson JL, Horvat JC, Preston JA, Dunkley ML, Foster PS, et al., 'Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease', PLoS Pathogens, 7 e1002244 (2011) [C1]
2011Hazlewood LC, Wood LG, Hansbro PM, Foster PS, 'Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma', Journal of Nutritional Biochemistry, 22 95-100 (2011) [C1]
2011Wu D, Ahrens R, Osterfeld H, Noah TK, Groschwitz K, Foster PS, et al., 'Interleukin-13 (IL-13)/IL-13 receptor1 (IL-13R1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion', Journal of Biological Chemistry, 286 13357-13369 (2011) [C1]
2011Hansbro PM, Kaiko GE, Foster PS, 'Cytokine/anti-cytokine therapy - Novel treatments for asthma?', British Journal of Pharmacology, 163 81-95 (2011) [C2]
2010Wood LG, Hazlewood LC, Foster PS, Hansbro PM, 'Lyprinol reduces inflammation and improves lung function in a mouse model of allergic airways disease', Clinical and Experimental Allergy, 40 1785-1793 (2010) [C1]
2010Kaiko GE, Phipps S, Angkasekwinai P, Dong C, Foster PS, 'NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25', Journal of Immunology, 185 4681-4690 (2010) [C1]
2010Lau JY, Oliver BG, Baraket M, Beckett EL, Hansbro NG, Moir LM, et al., 'Fibulin-1 Is increased in asthma - A novel mediator of airway remodeling?', Plos One, 5 1-13 (2010) [C1]
2010Thorburn AN, O'Sullivan BJ, Thomas R, Kumar RK, Foster PS, Gibson PG, Hansbro PM, 'Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease', Thorax, 65 1053-1060 (2010) [C1]
2010Siegle JS, Hansbro NG, Herbert C, Rosenberg HF, Domachowske JB, Asquith KL, et al., 'Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice', Respiratory Research, 11 1-15 (2010) [C1]
2010Hutchinson MR, Loram LC, Zhang Y, Shridhar M, Rezvani N, Berkelhammer D, et al., 'Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity', Neuroscience, 168 551-563 (2010) [C1]
2010Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Journal of Allergy and Clinical Immunology, 125 617-625 (2010) [C1]
2010Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, Gibson PG, et al., 'Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease', Journal of Immunology, 184 4159-4169 (2010) [C1]
2010Li J, Wang W, Baines KJ, Bowden NA, Hansbro PM, Gibson PG, et al., 'IL-27/IFN-y induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages', Journal of Immunology, 185 4401-4409 (2010) [C1]
2010Wang W, Li J, Foster PS, Hansbro PM, Yang M, 'Potential therapeutic targets for steroid-resistant asthma', Current Drug Targets, 11 957-970 (2010) [C1]
2010Yang M, Kumar RK, Foster PS, 'Interferon-Y and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness', Clinical and Experimental Allergy, 40 163-173 (2010) [C1]
2010Burgess JK, Boustany S, Moir LM, Weckmann M, Lau JY, Grafton K, et al., 'Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness', American Journal of Respiratory and Critical Care Medicine, 181 106-115 (2010) [C1]
2010Herbert C, Scott MM, Scruton KH, Keogh RP, Yuan KC, Hsu K, et al., 'Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma', American Journal of Pathology, 177 1657-1664 (2010) [C1]
2009Yang M, Kumar RK, Foster PS, 'Pathogenesis of steroid-resistant airway hyperresponsiveness: Interaction between IFN-gamma and TLR4/MyD88 pathways', Journal of Immunology, 182 5107-5115 (2009) [C1]
2009Percopo CM, Qiu Z, Phipps S, Foster PS, Domachowske JB, Rosenberg HF, 'Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice', Journal of Immunology, 183 604-612 (2009) [C1]
2009Bertram CM, Misso NL, Fogel-Petrovic M, Figueroa CD, Foster PS, Thompson PJ, Bhoola KD, 'Expression of kinin receptors on eosinophils: Comparison of asthmatic patients and healthy subjects', Journal of Leukocyte Biology, 85 544-552 (2009) [C1]
2009Mattes J, Collison AM, Plank MW, Phipps S, Foster PS, 'Antagonism of microRNA-126 suppresses the effector function of T(H)2 cells and the development of allergic airways disease', Proceedings of the National Academy of Sciences of the United States of America, 106 18704-18709 (2009) [C1]
2009Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC, 'Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: Identification of a novel pathway for regulating allergic inflammation', Journal of Immunology, 182 5393-5399 (2009) [C1]
2009Phipps S, Lam CE, Kaiko GE, Foo A, Collison AM, Mattes J, et al., 'Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th2 responses', American Journal of Respiratory and Critical Care Medicine, 179 883-893 (2009) [C1]
2009Knott ML, Matthaei KI, Foster PS, Dent LA, 'The roles of eotaxin and the STAT6 signalling pathway in eosinophil recruitment and host resistance to the nematodes Nippostrongylus brasiliensis and Heligmosomoides bakeri', Molecular Immunology, 46 2714-2722 (2009) [C1]
2009Phipps S, Hansbro NG, Lam CE, Foo A, Matthaei KI, Foster PS, 'Allergic sensitization is enhanced in early life through toll-like receptor 7 activation', Clinical and Experimental Allergy, 39 1920-1928 (2009) [C1]
2009Kumar RK, Hitchins MP, Foster PS, 'Epigenetic changes in childhood asthma', Disease Models and Mechanisms: DMM, 2 549-553 (2009) [C1]
2009Collison AM, Foster PS, Mattes J, 'Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses', Clinical and Experimental Pharmacology and Physiology, 36 1049-1053 (2009) [C1]
2009De Vries A, Hazlewood LC, Fitch PM, Seckl JR, Foster PS, Howie SEM, 'High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia', Clinical & Experimental Allergy, 39 731-739 (2009) [C1]
2009Foster PS, Mattes J, 'IL-21 comes of age', Immunology and Cell Biology, 87 359-360 (2009) [C2]
2008Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS, 'The IL-3/IL-5/GM-CSF common beta receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation', Journal of Immunology, 180 1199-1206 (2008) [C1]

Co-authors: Philip Hansbro

2008Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK, 'Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma', Clinical and Experimental Allergy, 38 847-856 (2008) [C1]
2008Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, et al., 'IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity', Journal of Experimental Medicine, 205 897-913 (2008) [C1]
2008Foster PS, Rosenberg HF, Asquith KL, Kumar RK, 'Targeting eosinophils in asthma', Current Molecular Medicine, 8 585-590 (2008) [C1]
2008Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW, 'Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity', Journal of Immunology, 180 2225-2232 (2008) [C1]

Co-authors: Philip Hansbro

2008Zhou J, Wolf CR, Henderson CJ, Cai Y, Board PG, Foster PS, Webb DC, 'Glutathione transferase P1: An endogenous inhibitor of allergic responses in a mouse model of asthma', American Journal of Respiratory and Critical Care Medicine, 178 1202-1210 (2008) [C1]
2008Ito K, Herbert C, Siegle JS, Vuppusetty C, Hansbro NG, Thomas PS, et al., 'Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma', American Journal of Respiratory Cell and Molecular Biology, 39 543-550 (2008) [C1]
2008Foster PS, Hogan SP, Rosenberg HF, Moqbel R, PHIPPS S, Lacy P, et al., 'Eosinophils: Biological properties and role in health and disease', Clinical and Experimental Allergy, 38 709-750 (2008) [C1]
2008Gantier MP, Tong S, Behlke MA, Xu D, Phipps S, Foster PS, Williams BRG, 'TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages', Journal of Immunology, 180 2117-2124 (2008) [C1]
2008Kumar RK, Herbert C, Foster PS, 'The 'classical' ovalbumin challenge model of asthma in mice', Current Drug Targets, 9 485-494 (2008) [C1]
2008Mattes J, Collison AM, Foster PS, 'Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation', Current Opinion in Molecular Therapeutics, 10 150-157 (2008) [C1]

Co-authors: Joerg Mattes

2007Mattes J, Yang M, Foster PS, 'Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?', American Journal of Respiratory and Cellular Molecular Biology, 36 8-12 (2007) [C1]
2007Bertram CM, Baltic S, Misso NL, Bhoola KD, Foster PS, Thompson PJ, Fogel-Petrovic M, 'Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration', Journal of Leukocyte Biology, 81 1445-1454 (2007) [C1]
2007Preston JA, Essilfie AT, Horvat JC, Wade MA, Beagley KW, Gibson PG, et al., 'Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae', Vaccine, 25 8154-8162 (2007) [C1]
2007Phipps S, Lam CE, Foster PS, Matthaei KI, 'The contribution of toll-like receptors to the pathogenesis of asthma', Immunology and Cell Biology, 85 463-470 (2007) [C1]
2007Weckmann M, Collison A, Simpson JL, Kopp MV, Wark PA, Smyth MJ, et al., 'Critical link between TRAIL and CCL20 for the activation of T(H)2 cells and the expression of allergic airway disease', Nature Medicine, 13 1308-1315 (2007) [C1]
2007Rosenberg HF, Phipps S, Foster PS, 'Eosinophil trafficking in allergy and asthma', Journal of Allergy and Clinical Immunology, 119 1303-1310 (2007) [C1]
2007Webb DC, Yang M, Matthaei (Ext) K, Foster PS, 'Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell function', Journal of Immunology, 178 219-227 (2007) [C1]

Co-authors: Ming Yang

2007Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF, et al., 'Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus', Blood, 110 1578-1586 (2007) [C1]
2007Tumes DJ, Cormie J, Calvert MG, Stewart K, Nassenstein C, Braun A, et al., 'Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lung-derived eosinophils', Journal of Leukocyte Biology, 81 1362-1373 (2007) [C1]
2007Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, et al., 'Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease', American Journal of Respiratory and Critical Care Medicine, 176 556-564 (2007) [C1]
2007Knott ML, Matthaei KI, Giacomin PR, Wang H, Foster PS, Dent LA, 'Impaired resistance in early secondary Nippostrongylus brasiliensis infections in mice with defective eosinophilopoeisis', International Journal for Parasitology, 37 1367-1378 (2007) [C1]
2007Dyer KD, Czapiga M, Foster B, Foster PS, Kang EM, Lappas CM, et al., 'Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: The dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo', Journal of Immunology, 179 1693-1699 (2007) [C1]
2007Fogel-Petrovic M, Long JA, Misso NL, Foster PS, Bhoola KD, Thompson PJ, 'Physiological concentrations of transforming growth factor Beta1 selectively inhibit human dendritic cell function', International Immunopharmacology, 7 1924-1933 (2007) [C1]
2007Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, et al., 'Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance', JOURNAL OF IMMUNOLOGY, 178 4222-4229 (2007)
2006Prescott VE, Forbes E, Foster PS, Matthaei (Ext) K, Hogan SP, 'Mechanistic analysis of experimental food allergen-induced cutaneous reactions', Journal of Leukocyte Biology, 80 258-266 (2006) [C1]
2006Forbes E, Hulett M, Ahrens R, Wagner N, Smart V, Matthaei (Ext) K, et al., 'ICAM-1-dependent pathways regulate colonic eosinophilic inflammation', Journal of Leukocyte Biology, 80 330-341 (2006) [C1]
2006Siegle JS, Hansbro NG, Herbert C, Yang M, Foster PS, Kumar RK, 'Airway hyperreactivity in exacerbation of chronic asthma is independent of elosinophilic inflammation', American Journal of Respiratory Cell and Molecular Biology, 35 565-570 (2006) [C1]
2006Yang M, Mattes J, Hansbro PM, Foster PS, 'Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease', Drug Discovery Today: Therapeutic Strategies, 3 325-332 (2006) [C1]
2006Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS, 'Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity', Clinical and Experimental Allergy, 36 1575-1583 (2006) [C1]
2006Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmmermann N, Mahalingam S, et al., 'Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness', Journal of Immunology, 177 5595-5603 (2006) [C1]

Co-authors: Ming Yang

2006Bystrom J, Dyer KD, Ravin S, Naumann N, Stephany DA, Foster PS, et al., 'Interleukin-5 does not influence differential transcription of transmembrane and soluble isoforms of IL-5R alpha in vivo', European Journal of Haematology, 77 181-190 (2006) [C1]
2006Swartz JM, Dyer KD, Cheever AW, Ramalingam T, Pesnicak L, Domachowske JB, et al., 'Schistosoma mansoni infection in eosinophil lineage-ablated mice', Blood, 108 2420-2427 (2006) [C1]
2006Kumar RK, Webb DC, Herbert C, Foster PS, 'Interferon - as a possible target in chronic asthma', Inflammation and Allergy - Drug Targets, 5 253-256 (2006) [C1]
2006Yang M, Rangasamy D, Matthaei K, Frew A, Zimmmermann N, Mahalingham S, et al., 'Inhibition of arginase I activity by RNA interference attenuates interleukin-13 induced airways hyperresponsiveness', ACTA PHARMACOLOGICA SINICA, 27 266-266 (2006)
2005Prescott VE, Campbell PM, Moore A, Mattes J, Rothenberg ME, Foster PS, et al., 'Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity', Journal of Agricultural and Food Chemistry, 53 9023-9030 (2005) [C1]
2005Rolph MS, So T, Young T, Laybutt R, Commandeur ZA, Foster PS, et al., 'Control of obesity and glucose homeostasis by Th1/Th2 cytokines', INFLAMMATION RESEARCH, 54 S105-S106 (2005)
2004Webb DC, Matthaei KI, Cai Y, McKenzie ANJ, Foster PS, 'Polymorphisms in IL-4Ra correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13 -/- mice1', J Immunol, 172 1092-1098 (2004) [C1]
2004Forbes E, Smart V, D'Aprile A, Henry P, Yang M, Matthaei KI, et al., 'T Helper-2 Immunity Regulates Bronchial Hyperresponsiveness in Eosinophil-Associated Gastrointestinal Disease in Mice', Gastroenterology, 127 105-118 (2004) [C1]
2004Fulkerson PC, Zimmermann N, Brandt EB, Muntel EE, Doepker MP, Kavanaugh JL, et al., 'Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by INF-g (Mig, CXCL9)', Proceedings of the National Academy of Sciences of the USA, 101 1987-1992 (2004) [C1]
2004Kumar RK, Herbert C, Webb DC, Li L, Foster PS, 'Effects of anticytokine therapy in a mouse model of chronic asthma', Am, J Resp Crit Care Med, 170 1043-1048 (2004) [C1]
2004Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, et al., 'Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodelling in mice', Am J Resp Crit Care Med, 169 860-867 (2004) [C1]
2004Kumar RK, Herbert C, Foster PS, 'Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis', Clinical and Experimental Allergy, 34 567-575 (2004) [C1]
2004Hogan SP, Rothenberg ME, Forbes E, Smart VE, Matthaei KI, Foster PS, 'Chemokines in Eosinophil-associated Gastrointestinal Disorders', Current Allergy and Asthma Reports, 4 74-82 (2004) [C1]
2004Clark K, Simson L, Newcombe N, Koskinen AML, Mattes J, Lee NA, et al., 'Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen', Journal of Leukocyte Biology, 75 1001-1009 (2004) [C1]
2004Forbes E, Murase T, Yang M, Matthaei KI, Lee JJ, Lee NA, et al., 'Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase1', J Immunol, 172 5664-5675 (2004) [C1]

Co-authors: Ming Yang

2003Zimmermann N, Gurjit Khurana H, Foster PS, Rothenberg ME, 'Chemokines in asthma: Cooperative interaction between chemokines and IL-13', Journal of Allergy and Clinical Immunology, 111 227-242 (2003) [C1]
2003Mattes J, Hulett M, Xie W, Hogan S, Rothenburg ME, Foster P, Parish C, 'Immunotherapy of cytotoxic T cell resistant tumors by T helper 2 cells: an eotaxin and STAT6 dependent process', Journal of Experimental Medicine, 197 387-393 (2003) [C1]
2003Webb D, Mahalingam S, Cai Y, Matthaei K, Donaldson D, Foster PS, 'Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Ralpha-independent airway hyperreactivity', European Journal of Immunology, 33 3377-3385 (2003) [C1]
2003Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmerman N, Fulkerson P, et al., 'Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity', Journal of Allergy and Clinical Immunology, 112 935-943 (2003) [C1]
2003Smart V, Foster PS, Rothenberg ME, Higgins TJ, Hogan SP, 'A plant-based allergy vaccine suppresses experimental asthma via an IFN-y and CD4+ CD45RB low T cell-dependent mechanism', Journal of Immunology, 171 2116-2126 (2003) [C1]
2003Mattes J, Foster P, 'Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin', Current Drug Targets, 2 169-174 (2003) [C1]

Co-authors: Joerg Mattes

2003Kumar RK, Herbert C, Thomas PS, Wollin L, Beume R, Yang M, et al., 'Inhibition of Inflammation and Remodeling by Roflumilast and Dexamethasone in murine chronic asthma', Journal of Pharmacology and Experimental Therapeutics, 307 349-355 (2003) [C1]
2003Kruse S, Kuehr J, Moseler M, Kropp MV, Kurz T, Deichmann KA, et al., 'Polymorphisms in the IL18 gene are associated with specific sensitization to common allergens and allergic rhinitis', Journal of Allergy and Clinical Immunology, 111 117-122 (2003) [C1]
2003Zimmerman N, King NE, Laporte J, Yang M, Mishra A, Pope SM, et al., 'Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.', Journal of Clinical Investigation, 111 1863-1874 (2003) [C1]
2003Foster PS, Webb DC, Yang M, Herbert C, Kumar RK, 'Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma', Clinical and Experimental Allergy, 33 688-695 (2003) [C1]
2003Foster PS, Yang M, Mattes J, Kumar R, Webb D, 'Interleukin-13 and allergy', Modern Aspects of Immunobiology, 3 8-8 (2003)
2003Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, et al., 'Eotaxin-2 and 165 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 112 935-943 (2003)
2002Foster PS, Wong G, Yasuda S, Qi J, Mahalingam S, Mellor E, et al., 'Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal transducer and activator of transcription (STAT) 6-dependent pathway', Journal of Biological Chemistry, 277 1906-1915 (2002) [C1]
2002Foster PS, Martinez-Moczygemba M, Huston D, Corry D, 'Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease', Pharmacology and Therapeutics, 94 253-264 (2002) [C1]
2002Kumar R, Foster PS, 'Modeling allergic asthma in mice: pitfalls and opportunities', American Journal of Respiratory Cell and Molecular Biology, 27 267-272 (2002) [C1]
2002Mattes J, Yang M, Mahalinggam S, Kuehr J, Webb DC, Simson L, et al., 'Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and cotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.', J Exp Med. 195:1433-44, 1433-1444 (2002) [C1]

Co-authors: Joerg Mattes

2002Hogan S, Foster PS, Rothenberg M, 'Experimental analysis of eosinophil-associated gastrointestinal diseases', Current Opinion in Allergy and Clinical Immunology, 2 239-248 (2002) [C1]
2002Kumar R, Thomas P, Seetoo D-Q, Herbert C, McKenzie A, Foster PS, Lloyd A, 'Eotaxin expression by epithelial cells and plasma cells in chronic asthma', Laboratory Investigation, 82 495-504 (2002) [C1]
2002Mishra A, Hogan S, Brandt E, Wagner N, Crossman M, Foster PS, Rothenberg M, 'Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking', Journal of Biological Chemistry, 277 4406-4412 (2002) [C1]
2002Kumar R, Herbert C, Yang M, Koskinen A, McKenzie A, Foster PS, 'Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma', Clinical and Experimental Allergy, 32 1104-1111 (2002) [C1]
2002Foster PS, Yang M, Herbert C, Kumar R, 'CD4+ T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma', Laboratory Investigation, 82 455-462 (2002) [C1]
2002Truong-Tran A, Ruffin R, Foster PS, Koskinen A, Coyle P, Philcox J, et al., 'Altered zinc homeostasis and caspase-3 activity in murine allergic airway inflammation', American Journal of Respiratory Cell and Molecular Biology, 27 286-296 (2002) [C1]
2002Foster PS, Hogan S, Yang M, Mattes J, Young I, Matthaei K, et al., 'Interleukin-5 and eosinophils as therapeutic targets for asthma', Trends in Molecular Medicine, 8 162-167 (2002) [C2]

Co-authors: Joerg Mattes

2002Kumar R, Foster PS, 'ST2: marker, activator and regulator of Th2 immunity?', Clinical and Experimental Allergy, 32 1394-1396 (2002) [C2]
2002Foster PS, Mahalingam S, Meanger J, Lidbury B, 'The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses', Journal of Leukocyte Biology, 72 429-439 (2002) [C2]
2001Foster PS, Mahalingam S, Chaudhri G, Tan C, John A, Karupiah G, 'Transcription of the interferon (IFN-gamma)-inducible chemokine Mig in IFN-gamma-deficient Mice', Journal of Biological Chemistry, 276 7568-7574 (2001) [C1]
2001Kumar R, Foster PS, 'Murine model of chronic human asthma', Immunology and Cell Biology, 79 141-144 (2001) [C1]
2001Mattes J, Yang M, Siqueira A, Clark K, Mackenzie J, McKenzie A, et al., 'IL-13 induces airways hyperreactivity independently of the IL-4R{alpha} chain in the allergic lung', Journal of Immunology, 167 1683-1692 (2001) [C1]

Co-authors: Joerg Mattes

2001Yang M, Hogan S, Henry P, Matthaei K, McKenzie A, Young I, et al., 'Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin', American Journal of Respiratory Cell and Molecular Biology, 25 522-530 (2001) [C1]
2001Pope S, Brandt E, Mishra A, Hogan S, Zimmermann N, Matthaei K, et al., 'IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism', Journal of Allergy and Clinical Immunology, 108 594-601 (2001) [C1]
2001Webb D, McKenzie A, Matthaei K, Rothenberg M, Foster PS, 'Distinct spatial requirement for eosinophil-induced airways hyperreactivity', Immunology and Cell Biology, 79 165-169 (2001) [C1]
2001Zuegg J, Webb D, Foster PS, Casarotto M, 'Structural model of human IL-13 defines the spatial interactions with the IL-13alpha/IL-4Ralpha receptor', Immunology and Cell Biology, 79 332-339 (2001) [C1]
2001Hertz M, Mahalingam S, Dalum I, Klysner S, Mattes J, Neisig A, et al., 'Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma', Journal of Immunology, 167 3792-3799 (2001) [C1]

Co-authors: Joerg Mattes

2001Webb D, McKenzie A, Foster PS, 'Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein', Journal of Biological Chemistry, 276 1969-1976 (2001) [C1]
2001Mackenzie J, Mattes J, Dent L, Foster PS, 'Eosinophils promote allergic disease of the lung by regulating CD4+ Th2 lymphocyte function', Journal of Immunology, 167 3146-3155 (2001) [C1]

Co-authors: Joerg Mattes

2001Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmerman N, et al., 'A pathological role for cotaxin and eosinophils in experimental oral antigen-induced eosinophilic gastrointestinal inflammation.', Nat Immunol. 2:353-360, 353-360 (2001) [C1]
2001Mahalingam S, Clark K, Matthaei K, Foster PS, 'Antiviral potential of chemokines', BioEssays, 23 428-435 (2001) [C2]
2001Foster PS, Mould A, Yang M, Mackenzie J, Mattes J, Hogan S, et al., 'Elemental signals regulating eosinophil accumulation in the lung', Immunological Reviews, 179 173-181 (2001) [C2]

Co-authors: Joerg Mattes

2001Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al., 'A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation', NATURE IMMUNOLOGY, 2 353-360 (2001)
2000Webb D, McKenzie A, Koskinen A, Yang M, Mattes J, Foster PS, 'Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity', Journal of Immunology, 165 108-113 (2000) [C1]

Co-authors: Joerg Mattes

2000Foster PS, Ming Y, Matthei K, Young I, Temelkovski J, Kumar R, 'Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma', Laboratory Investigation, 80 655-662 (2000) [C1]
2000Mould A, Ramsay A, Matthaei K, Young I, Rothenberg M, Foster PS, 'The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity', Journal of Immunology, 164 2142-2150 (2000) [C1]
2000Mahalingam S, Foster PS, Lobigs M, Farber J, Karupiah G, 'Interferon-inducible chemokines and immunity to poxvirus infections', Immunological Reviews, 177 127-133 (2000) [C3]
1999Xiong Y, Karupiah G, Hogan S, Foster PS, Ramsay A, 'Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2', Journal of Immunology, 162 445-452 (1999) [C1]
1999Foster PS, Hogan S, 'The use of murine models to investigate the immune metworks underlying asthma', Current Opinion in Anti-inflammatory and Immunomod, 1 433-441 (1999) [C1]
1999Mishra A, Hogan S, Lee J, Foster PS, Rothenberg M, 'Fundamental signals that regulate eosinophil homing to the gastrointestinal tract', Journal of Clinical Investigation, 103 1719-1727 (1999) [C1]
1999Foster PS, 'Allergic networks regulating eosinophilia', American Journal of Respiratory Cell and Molecular Biology, 21 451-454 (1999) [C2]
1999Rothenberg M, Zimmermann N, Mishra A, Brandt E, Birkenberger L, Hogan S, Foster PS, 'Chemokines and chemokine receptors: their role in allergic airway disease', Journal of Clinical Immunology, 19 250-265 (1999) [C2]
1999Foster PS, 'STAT6: an intracellular target for the inhibition of allergic disease', Clinical and Experimental Allergy, 29 12-16 (1999) [C3]
1998Temelkovski J, Hogan S, Shepherd D, Foster PS, Kumar R, 'An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen', Thorax, 53 849-856 (1998) [C1]
1998Hogan S, Matthaei K, Young J, Koskinen A, Young I, Foster PS, 'A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5', Journal of Immunology, 161 1501-1509 (1998) [C1]
1998Hogan S, Koskinen A, Matthaei K, Young I, Foster PS, 'Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice', American Journal of Respiratory and Critical Care Medicine, 157 210-218 (1998) [C1]
1998Hogan S, Foster PS, Tan X, Ramsay A, 'Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity', European Journal of Immunology, 28 413-423 (1998) [C1]
1997Hogan S, Mould A, Kikutani H, Ramasy A, Foster PS, 'Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins', Journal of Clinical Investigation, 99 1329-1339 (1997) [C1]
1997Kourie J, Foster PS, Dulhunty A, 'Inositol polyphosphates modify the kinetics of a small chloride channel in skeletal muscle sarcoplasmic reticulum', Journal of Membrane Biology: an international journal for studies on the structure function and genesis of biomembranes, 157 147-158 (1997) [C1]
1997Mould A, Matthaei K, Young I, Foster PS, 'Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice', Journal of Clinical Investigation, 99 1064-1071 (1997) [C1]
1997Foster PS, Hogan S, Matthaei K, Young I, 'Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity', Memorias do Instituto Oswaldo Cruz Rio de Janeiro, 92 55-61 (1997) [C1]
1997Matthaei K, Foster PS, Young I, 'The role of interleukin-5 (IL-5) in vivo: Studies with IL-5 deficient mice', Memorias do Instituto Oswaldo Cruz Rio de Janeiro, 92 63-68 (1997) [C1]
1997Hogan S, Koskinen A, Foster PS, 'Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice', Immunology and Cell Biology, 75 284-288 (1997) [C1]
1997Hogan S, Foster PS, 'Cytokines as targets for the inhibition of eosinophilic inflammation', Pharmacology and Therapeutics, 74 259-283 (1997) [C2]
1996Foster PS, Hogan S, Ramsay A, Matthaei K, Young I, 'Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model', Journal of Experimental Medicine, 183 195-201 (1996) [C1]
1996Denborough M, Hopkinson K, O'Brien R, Foster PS, 'Overheating alone can trigger malignant hyperthermia in piglets', Anaesthesia and Intensive Care, 24 348-354 (1996) [C1]
1996Hogan S, Foster PS, 'Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo', Medicinal Research Reviews, 16 407-432 (1996) [C1]
1995O'Brien R, Taske N, Hansbro P, Matthaei K, Hogan S, Denborough M, Foster PS, 'Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia', Journal of Medical Genetics, 32 913-914 (1995) [C1]

Co-authors: Philip Hansbro

1995Taske N, Eyre H, O'Brien R, Sutherland G, Denborough M, Foster PS, 'Molecular cloning of the cDNA encoding human skeletal muscle triadin and its localisation to chromosome 6q22-6q23', The Federation of European Biochemical Societies (FEBS) Journal, 233 258-265 (1995) [C1]
1994Hansbro P, Foster PS, Hogan S, Ozaki S, Denborough M, 'Purification and characterization of D-myo-Inositol (1,4,5)/(1,3,4,5)-polyphosphate 5-phosphatase from skeletal muscle', Archives of Biochemistry and Biophysics, 311 47-54 (1994) [C1]

Co-authors: Philip Hansbro

1994Foster PS, 'The role of phosphoinositide metabolism in Ca2+ signalling of skeletal muscle cells', The International Journal of Biochemistry and Cell Biology, 26 449-468 (1994) [C1]
1994Foster PS, Hansbro P, Liu C, Potter B, Denborough M, 'Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism', Biochemical and Biophysical Research Communications, 200 8-15 (1994) [C1]

Co-authors: Philip Hansbro

1994Foster PS, Hogan S, Hansbro P, O'Brien R, Potter B, Ozaki S, Denborough M, 'The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle', European Journal of Biochemistry, 222 955-964 (1994) [C1]

Co-authors: Philip Hansbro

1994Hogan S, Foster PS, Hansbro P, Ozaki S, Denborough M, 'Detection and partial purification of inositol 1,4,5-trisphosphate 3-kinase from porcine skeletal muscle', Cellular Signalling, 6 233-243 (1994) [C1]

Co-authors: Philip Hansbro

1993Foster PS, Denbobourgh M, 'The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle', The International Journal of Biochemistry and Cell Biology, 25 495-504 (1993) [C1]
1993Foster PS, Gesini E, Denborough M, 'Inositol 1,4,5-trisphosphate metabolism in red blood cells from individuals susceptible to malignant hyperpyrexia', Lancet, 342 986-987 (1993) [C3]
1992Foster PS, Hopkinson K, Denborough M, 'Propofol anaesthesia in malignant hyperpyrexia susceptible swine', Clinical and Experimental Pharmacology and Physiology, 19 183-186 (1992) [C1]
1991Foster PS, Hopkinson K, Payne N, Denborough M, 'The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle', Clinical and Experimental Pharmacology and Physiology, 18 489-495 (1991) [C1]
1990Foster PS, 'Malignant hyperpyrexia (Short Survey)', The International Journal of Biochemistry and Cell Biology, 22 1217-1222 (1990) [C1]
1990FOSTER PS, 'MALIGNANT HYPERPYREXIA', INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 22 1217-1222 (1990)
1989Foster PS, Hopkinson K, Denborough M, '31P-NMR spectroscopy: The metabolic profile of malignant hyperpyrexic porcine skeletal muscle', Muscle and Nerve, 12 390-396 (1989) [C1]
1989Foster PS, Hopkinson K, Denborough M, 'Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle', Clinical and Experimental Pharmacology and Physiology, 16 799-805 (1989) [C1]
1989Foster PS, Denborough M, 'Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle', British Journal of Anaesthesia, 62 566-572 (1989) [C1]
1989Foster PS, Hopkinson K, Denborough M, 'Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane', British Journal of Anaesthesia, 62 560-565 (1989) [C1]
1989Foster PS, Claudianos C, Gesini E, Hopkinson K, Denborough M, 'Inositol 1,4,5,-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine', Lancet, 2 124-127 (1989) [C1]
1989Foster PS, White M, Denborough M, 'Characterization of the terminal cisternae and longitudinal tubules of sarcoplasmic reticulum from malignant hyperpyrexia susceptible porcine skeletal muscle', International Journal of Biochemistry, 21 1119-1126 (1989) [C1]
1989Foster PS, Hopkinson K, Denborough MA, 'P-NMR spectroscopy: The metabolic profile of malignant hyperpyrexic porcine skeletal muscle', Muscle and Nerve, 12 390-396 (1989)
1983Foster PS, Goldie R, Paterson J, Spina D, 'Effect of hypothermia on beta 1-adrenoceptor-mediated relaxation of pig bronchus', British Journal of Pharmacology, 80 699-702 (1983) [C1]
1983Foster PS, Goldie R, Paterson J, 'Effect of steroids on beta-adrenoreceptor-mediated relaxation of pig bronchus', British Journal of Pharmacology, 78 441-445 (1983) [C1]
Show 200 more

Conference (105 outputs)

YearCitationAltmetricsLink
2013Tay H, Kaiko G, Hansbro P, Foster P, 'The role of miRNA in regulating bacterial clearance', JOURNAL OF IMMUNOLOGY, Honolulu, HI (2013) [E3]
2013Kim RY, Horvat JC, Starkey MR, Essilfie A-T, Foster PS, Hansbro PM, 'MICRORNA INHIBITION IN NEONATAL CHLAMYDIA LUNG INFECTION PREVENTS INFECTION-INDUCED LUNG PATHOLOGY IN LATER LIFE', RESPIROLOGY (2013) [E3]
2013Hatchwell L, Collison A, Phipps S, Foster PS, Johnston SL, Mattes J, 'CCL7 (MCP-3) MEDIATES RHINOVIRUS-INDUCED LUNG INFLAMMATION AND EXACERBATION OF ALLERGIC AIRWAY DISEASE', RESPIROLOGY (2013) [E3]
2013Hansbro P, Horvat J, Essilfie A-T, Kim R, Mayall J, Starkey M, Foster P, 'Macrolides suppress key features of experimental steroid-sensitive and steroid-resistant asthma', JOURNAL OF IMMUNOLOGY, Honolulu, HI (2013) [E3]
2013Herbert C, Siegle JS, Shadie AM, Nikolaysen S, Garthwaite L, Hansbro NG, et al., 'EARLY LIFE EXPOSURE TO ENVIRONMENTAL PARTICULATES PREDISPOSES TO DEVELOPMENT OF ASTHMATIC INFLAMMATION', RESPIROLOGY (2013) [E3]
2013Hansbro P, Beckett E, Stevens R, Jarnicki A, Kim R, Hanish I, et al., 'A short-term model of COPD identifies a role for mast cell tryptase', JOURNAL OF IMMUNOLOGY, Honolulu, HI (2013) [E3]
2013Girkin J, Hatchwell L, Foster PS, Johnston SL, Collison A, Mattes J, 'SALMETEROL ATTENUATES CHEMOTAXIS IN RHINOVIRUS-INDUCED EXACERBATION OF ASTHMA VIA MODULATION OF PP2A', RESPIROLOGY (2013) [E3]
2013Horvat JC, Essilfie A-T, Kim RY, Mayall JR, Starkey MR, Beckett EL, et al., 'MACROLIDES SUPPRESS KEY FEATURES OF EXPERIMENTAL STEROID-SENSITIVE AND STEROID-RESISTANT ASTHMA', RESPIROLOGY (2013) [E3]
2012Starkey MR, Kim RY, Horvat JC, Essilfie A-T, Beagley KW, Mattes J, et al., 'Constitutive IL-13 promotes respiratory chlamydial infection-induced chronic airway hyperresponsiveness', Respirology, Canberra, ACT (2012) [E3]
2012Starkey M, Kim R, Horvat J, Essilfie A-T, Beagley K, Mattes J, et al., 'Constitutive IL-13 promotes respiratory chlamydial infection and infection-induced chronic airway hyper-responsiveness', JOURNAL OF IMMUNOLOGY, Boston, MA (2012) [E3]
2012Tay HL, Kaiko GE, Plank MW, Mattes J, Hansbro PM, Foster PS, 'MiRNAs regulate bacterial infection in lungs', Respirology, Canberra, ACT (2012) [E3]
2012Horvat JC, Essilfie A-T, Kim RY, Mayall JR, Starkey MR, Beckett EL, et al., 'Efficacy of antibiotic-based therapeutic strategies for the treatment of infection-induced, steroid-resistant allergic airways disease', Respirology, Canberra, ACT (2012) [E3]
2012Kaiko GE, Tay HL, Plank MW, Hansbro PM, Foster PS, 'MicroRNA regulate bacterial phagocytosis in the lung', Immunology: Abstracts of the European Congress of Immunology, Glasgow, Scotland (2012) [E3]

Co-authors: Philip Hansbro

2012Kaiko GE, Phipps S, Plank MW, Tay HL, Lam CE, Foster PS, 'Inhibition of microRNA reverses CD8 T cell exhaustion and improves immunity against respiratory virus infection', Respirology, Canberra, ACT (2012) [E3]
2012Plank MW, Kaiko GE, Luck H, Li J, Mattes J, Hansbro PM, Foster PS, 'The role of micrornas in CD4 T cell function', Respirology, Canberra, ACT (2012) [E3]
2012Hatchwell LM, Collison AM, Siqueira AP, Bartlett NW, Johnston SL, Foster PS, Mattes J, 'Toll-like receptor 7 mediates anti-viral responses to rhinovirus while suppressing exacerbation of asthma', Respirology, Canberra, ACT (2012) [E3]

Co-authors: Joerg Mattes

2012Collison AM, Hatchwell LM, Siqueira AP, Bartlett NW, Johnston SL, Foster PS, Mattes J, 'Antagonism of microRNA-122 is comparible to azithromycin treatment in a mouse model of rhinovirus-induced exacerbation of allergic airways disease', Respirology, Canberra, ACT (2012) [E3]

Co-authors: Joerg Mattes

2012Hatchwell LM, Collison AM, Siqueira AP, Bartlett NW, Johnston SL, Foster PS, Mattes J, 'TRAIL regulates inflammatory responses to rhinovirus and rhinovirus-induced exacerbation of asthma', Respirology, Canberra, ACT (2012) [E3]

Co-authors: Joerg Mattes

2012Li J, Foster PS, Yang M, 'Inducible microRNA-X expression underpins steroid- resistant airway hyperresponsiveness by upregulating IL-27 expression', Respirology, Canberra, ACT (2012) [E3]

Co-authors: Ming Yang

2011Horvat JC, Essilfie A-T, Kim RY, Simpson JL, Dunkley ML, Beagley KW, et al., 'Investigation of infection-induced steroid resistant asthma', Respirology, Perth, WA (2011) [E3]
2011Collison AM, Hatchwell LM, Pereira De Siqueira AL, Don A, Verrills NM, Foster PS, Mattes J, 'The development of house dust mite-induced allergic airways disease is regulated by a novel E3 ubiquitin ligase-dependent deactivation of a protein phosphatase', Respirology, Perth, WA (2011) [E3]
2011Foster PS, Tay HL, Kaiko GE, Plank MW, Mattes J, Hansbro PM, 'MiRNA and its roles in regulating bacterial infection in lungs', American Journal of Respiratory and Critical Care Medicine, Denver, CO (2011) [E3]
2011Mattes J, Hankin RG, Hilton JM, Collison AM, Pereira De Siqueira AL, Gulliver T, et al., 'Frequent persistent wheeze in infancy may be associated with impaired FEV0.5 and FVC values', Respirology, Perth, WA (2011) [E3]

Co-authors: Joerg Mattes

2011Hatchwell LM, Collison AM, Pereira De Siqueira AL, Foster PS, Verrills NM, Don A, et al., 'A novel E3 ubiquitin ligase links rhinovirus infection to exacerbation of asthma', Respirology, Perth, WA (2011) [E3]
2011Wu DXY, Ahrens R, Osterfeld H, Groschwitz K, Foster P, Rothenberg ME, et al., 'Interleukin-13 (IL-13)/IL-13 receptor alpha 1 (IL-13R alpha 1) signaling regulates intestinal epithelial Cystic fibrosis transmembrane conductance regulator (CFTR) channel-dependent Cl- secretion', FASEB JOURNAL, Washington, DC (2011) [E3]
2011Hansbro PM, Horvat JC, Essilfie A-T, Kim RY, Simpson JL, Dunkley ML, et al., 'Infection-induced neutrophilic allergic airways disease is resistant to steroid treatment', American Journal of Respiratory and Critical Care Medicine, Denver, CO (2011) [E3]
2010Foster PS, Mattes J, Collison AM, Plank MW, Phipps S, 'MicoRNAs bridge innate and adative immunity: induction of TH2 mediated allergic airways disease', OzBio 2010: The Molecules of Life - from Discovery to Biotechnology. Abstracts, Melbourne, Vic (2010) [E3]

Co-authors: Joerg Mattes

2010Herbert C, Scott MM, Keogh R, Siegle JS, Yuan K, Tedla N, et al., 'Alternatively activated alveolar macrophages stimulate Th2 cytokine production by primed CD4+ T cells in a model of an acute exacerbation of asthma', American Journal of Respiratory and Critical Care Medicine, New Orleans (2010) [E3]
2010Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae vaccine, prevenar, induces regulatory T cells and prevents allergic airways disease', American Journal of Respiratory and Critical Care Medicine, New Orleans (2010) [E3]
2010Ptaschinski CM, Adachi R, Rosenberg HF, Stevens RL, Foster PS, 'Beneficial role for the tryptase mouse mast cell protease 6 in the innate immune response in the lung to pneumonia virus of mice', Translational Science: From Basic to Clinincal Immunology and Allergy, Ischia, Italy (2010) [E3]
2010Hansbro PM, Essilfie A-T, Simpson JL, Dunkley ML, Horvat JC, Gibson PG, Foster PS, 'Haemophilus influenzae induces IL-17-mediated neutrophilic allergic airways disease', American Journal of Respiratory and Critical Care Medicine, New Orleans (2010) [E3]
2010Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Development of a streptococcus pneumoniae-based immunoregulatory therapy for asthma', American Journal of Respiratory and Critical Care Medicine, New Orleans (2010) [E3]
2010Lam CE, Foo A, Essilfie A-T, Hansbro PM, Matthaei KI, Foster PS, Phipps S, 'Chemerin derived peptide reduces LPS and haemophilus influenza-induced emphysema in mice', Respirology, Brisbane, QLD (2010) [E3]

Co-authors: Philip Hansbro

2010Ptaschinski CM, Phipps S, Hansbro NG, Rosenberg HF, Mattes J, Foster PS, 'MicroRNAs are involved in the regulation of inflammatory responses characteristic of severe respiratory virus infection', American Journal of Respiratory and Critical Care Medicine, New Orleans (2010) [E3]
2010Siegle J, Hansbro NG, Dong C, Angkasekwinai P, Foster PS, Kumar R, 'Anti-Th2 cytokines inhibit progression in a murine model of childhood asthma', European Respiratory Society Annual Congress 2010. Abstracts, Barcelona, Spain (2010) [E3]

Co-authors: Nicole Hansbro

2010Mattes J, Collison AM, Plank MW, Phipps S, Foster PS, 'The role of microRNA as new anti-inflammatory targets', APCAACI 2010: The 8th Asia Pacific Congress on Allergy, Asthma and Clinical Immunology Programme & Abstracts Handbook, Singapore (2010) [E3]

Co-authors: Joerg Mattes

2010Foo A, Lam CE, Foster PS, Phipps S, 'Regulatory T cells suppress the formation of inducible bronchus-associated lymphoid tissue in weanling mice', Respirology, Brisbane, QLD (2010) [E3]
2009Horvat JC, Starkey MR, Beagley KW, Gibson PG, Foster PS, Hansbro PM, 'Chlamydial respiratory infection predisposes to neutrophil dominated allergic airways disease (AAD)', Journal of Immunology, Seattle, WASH. (2009) [E3]
2009Essilfie A-T, Simpson JL, Dunkley ML, Foster PS, Gibson PG, Hansbro PM, 'Haemophilus influenzae infection induces features of neutrophilic asthma', Respirology, Darwin, NT (2009) [E3]
2009Thorburn AN, O'Sullivan B, Thomas R, Foster PS, Gibson PG, Hansbro PM, 'Prevenar suppresses allergic airways disease through the expansion of regulatory T cells', Respirology, Darwin, NT (2009) [E3]
2009Wu DX, Ahrens RE, Groschwitz KR, Osterfield HN, Foster PS, Finkelman FD, et al., 'Elevated intestinal interleukin-13 promotes intestinal epithelial barrier dysfunction', The Journal of Allergy and Clinical Immunology, Washington, DC (2009) [E3]
2009Weckmann M, Lau J, Grafton K, Oliver B, Hansbro NG, Foster PS, et al., 'Tumstatin: A non-collagenous domain of collagen IV: Effects on inflammation and angiogenesis', Respirology, Darwin, NT (2009) [E3]
2009Foo A, Lam CE, Foster PS, Phipps S, 'Regulatory T cells suppress the development of inducible bronchus-associated lymphoid tissue (iBALT) in weanling mice', 39th Annual Meeting of the Australasian Society for Immunology: Program, Broadbeach, QLD (2009) [E3]
2009Horvat JC, Starkey MR, Beagley KW, Preston JA, Gibson PG, Foster PS, Hansbro PM, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease (AAD)', Respirology, Darwin, NT (2009) [E3]
2009Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Respirology, Darwin, NT (2009) [E3]
2009Lam CE, Foo A, Matthaei KI, Foster PS, Phipps S, 'Repeated stimulation of toll-like receptor 4 is sufficient to induce emphysematous lesions in mice', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]
2009Hansbro PM, Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Foster PS, 'Early life chlamydial infection enhances allergic airways disease through age-dependent differences in immunopathology', Journal of Immunology, Seattle, WASH. (2009) [E3]
2009Foo A, Lam CE, Wark PA, Foster PS, Phipps S, 'Immune mechanisms that promote the development of inducible bronchus-associated lymphoid tissue (iBALT)', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]

Co-authors: Peter Wark

2009Hansbro PM, Thorburn AN, Foster PS, Gibson PG, 'Streptococcus pneumoniae vaccine, Prevenar, utilises Tregs to suppress asthma', Journal of Immunology, Seattle, WASH. (2009) [E3]
2009Collison AM, De Siqueira A, Plank MW, Foster PS, Mattes J, 'The identification of TRAIL as a mediator of airways remodelling in a chronic model of murine allergic airways disease', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]

Co-authors: Joerg Mattes

2009Siegle JS, Hansbro NG, Herbert C, Rosenberg HF, Asquith KL, Foster PS, Kumar RK, 'Interaction between early-life viral infection and allergen exposure induces an asthmatic phenotype in mice', Respirology, Darwin, NT (2009) [E3]
2009Herbert C, Scruton K, Hsu K, Siegle JS, Hansbro NG, Foster PS, et al., 'Enhanced expression of cytokines by pulmonary T-cells and macrophages in a model of exacerbations of chronic asthma', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]

Co-authors: Nicole Hansbro

2009Mattes J, Collison AM, Plank MW, Phipps S, Foster PS, 'MicroRNAs regulate allergic airway inflammation', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]

Co-authors: Joerg Mattes

2009Collison AM, Mattes J, Phipps S, Plank MW, Foster PS, 'MicroRNAs are crucial in the development of airways hyperreactivity', American Journal of Respiratory and Critical Care Medicine, San Diego, CA (2009) [E3]

Co-authors: Joerg Mattes

2008Horvat JC, Beagley KW, Gibson PG, Foster PS, Hansbro PM, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease', Respirology, Melbourne, VIC (2008) [E3]
2008Hansbro PM, Thorburn AN, Foster PS, Gibson PG, 'Streptococcus Pneumoniae vaccine prevenar: A potential therapy for the suppression of asthma', American Journal of Respiratory and Critical Care Medicine, Toronto, ONT (2008) [E3]
2008Hansbro PM, Essilfie A-T, Foster PS, Gibson PG, 'Haemophilus influenzae (Hi) infection in asthma may drive the development of neutrophilic asthma (NA)', American Journal of Respiratory and Critical Care Medicine, Toronto, ONT (2008) [E3]
2008Asquith KL, Ramshaw H, Lopez A, Foster PS, 'The IL-3/IL-5/GM-CSF Common beta Receptor Plays a Pivotal Role in Regulating Th2 Immunity and Allergic Airway Inflammation', FASEB JOURNAL (2008) [E3]
2008Burgess JK, Boustany S, Oliver BG, Moir LM, Baraket M, Hansbro PM, et al., 'The absence of tumstatin in asthma may lead to angiogenesis and airway hyperresponsiveness', American Journal of Respiratory and Critical Care Medicine, Toronto, ONT (2008) [E3]
2008Hazelwood L, Wood LG, Hansbro PM, Foster PS, 'High fat diet reduces eosinophilic lung inflammation via nicotinic acetylcholine-dependent signaling', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book, Canberra, ACT (2008) [E3]
2008Starkey MR, Horvat JC, Kim RY, Phipps S, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book, Canberra, ACT (2008) [E3]
2008Thorburn AN, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae vaccine prevenar: A potential therapy for the suppression of asthma', Respirology, Melbourne, VIC (2008) [E3]
2008Yang M, Ma C, Foster PS, 'Antigen-specific TH1 cells induce airway hyper-reactivity in co-operation with lipopolysaccharide in BALB/C mice', Respirology, Melbourne, VIC (2008) [E3]
2008Hansbro NG, Boustany S, Oliver B, Burgess J, Black J, Rosenberg H, et al., 'Early life pneumoviral infection induces the development of pulmonary angiogenesis', Respirology, Melbourne, VIC (2008) [E3]
2008Essilfie A-T, Preston JA, Horvat JC, Dunkley ML, Foster PS, Gibson PG, et al., 'Haemophilus influenzae (Hi) infection in asthma may drive the development of neutrophilic asthma (NA)', Respirology, Melbourne, VIC (2008) [E3]
2008Thorburn AN, O'Sullivan BJ, Thomas R, Foster PS, Gibson PG, Hansbro PM, 'Suppression of allergic airways disease by the Streptococcus pneumoniae vaccine prevenar through the induction of regulatory T cells', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book, Canberra, ACT (2008) [E3]
2008Hansbro PM, Horvat JC, Beagley KW, Gibson PG, Foster PS, 'Neutrophil influx during chlamydial lung infection determines the phenotype of allergic airways disease', American Journal of Respiratory and Critical Care Medicine, Toronto, ONT (2008) [E3]
2008Boustany S, Oliver BG, Moir LM, Black JL, Hansbro PM, Hansbro NG, et al., 'Tumstatin, an angiogenic inhibitor, modulates airway angiogenesis', Respirology, Melbourne, VIC (2008) [E3]
2008Hansbro PM, Essilfie A-T, Simpson JL, Dunkley ML, Gibson PG, Foster PS, 'Haemophilus influenzae (HI) infection induces features of neutrophilic asthma', Australasian Society for Immunology 38th Annual Scientific Meeting: Delegate Book, Canberra, ACT (2008) [E3]
2007Simosn L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, et al., 'Potential role for eosinophils in tumor immune surveillance', Proceedings of the 13th International Congress on Immunology, Rio de Janeiro, Brazil (2007) [E1]
2007Horvat JC, Moller CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'Allergic airways disease (AAD) is differentially affected by chlamydial lung infection at different stages of life', Respirology (TSANZ Abstracts-Posters), Auckland (2007) [E3]
2007Kaiko GE, Phipps S, Foster PS, 'Respiratory Syncytial Virus up-regulates PD-1 expression; comparison to a model of CD8 T cell exhaustion in BALB/c mice', Immuno 2007: 13th International Congress of Immunology, Abstracts and Posters, Rio de Janeiro, Brazil (2007) [E3]
2007Ferguson AL, Beagley KW, Hansbro PM, Foster PS, 'CD4+ T-cell programming by adult and neonatal bacterial infections inhibit the development of allergic airway inflammation in later life', Immuno 2007: 13th International Congress on Immunology. Abstracts and Posters, Rio de Janeiro, Brazil (2007) [E3]

Co-authors: Philip Hansbro

2007Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Development of allergic airways disease (AAD) is differentially affected by the timing of chlamydial infection relative to allergic sensitization', American Journal of Respiratory and Critical Care Medicine, San Francisco, Calif. (2007) [E3]
2007Horvat JC, Garside CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'Development of allergic airways disease is differentially affected by chlamydial respiratory infection at different ages', American Journal of Respiratory and Critical Care Medicine, San Francisco, Calif. (2007) [E3]
2007Essiflie A, Preston JA, Horvat JC, Dunkley ML, Foster PS, Gibson PG, et al., 'Elucidating the association between Haemophilus influenzae infection and neutrophilic allergic airways disease using mouse models', Immuno 2007: 13th International Congress of Immunology. Abstracts and Posters, Rio de Janeiro, Brazil (2007) [E3]
2007Hansbro NG, Boustany S, Oliver BG, Burgess JK, Black JL, Hansbro PM, Foster PS, 'Viral-induced angiogenesis', Immuno 2007: 13th International Congress of Immunology. Abstracts and Posters, Rio de Janeiro, Brazil (2007) [E3]
2007Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Timing of chlamydial infection relative to allergen exposure differentially affects allergic airways disease', Respirology (TSANZ Abstracts-Posters), Auckland (2007) [E3]
2007Phipps S, Lam CE, Kaiko GE, Collison A, Smith L, Mansell A, et al., 'Contribution of multiple toll-like receptors to the development of murine allergic airways inflammation', Immunology and Cell Biology, Manly, NSW (2007) [E3]
2007Kaiko GE, Phipps S, Foster PS, 'Importance of CD4 T cells in the clearance of a primary Respiratory Syncytial Virus infection and in protection against the development of exhausted CD8 T cell memory', Immunology and Cell Biology, Manly, NSW (2007) [E3]
2007Forbes EE, Groschwitz KR, Ahrens R, Brandt EB, Rothenberg ME, Foster PS, et al., 'Role of Th2-molecules in OVA-induced intestinal anaphylaxis', Journal of Allergy and Clinical Immunology (Program and Abstracts of Papers to be Presented During Scientific Sessions - 2007 AAAAI Annual Meeting), San Diego, California (2007) [E3]
2006Horvat JC, Wade MA, Preston JA, Hansbro NG, Gibson PG, Beagley KW, et al., 'Early life chlamydial lung infection enhances allergic airways disease (AAD)', Respirology, Canberra (2006) [E3]
2006Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'The influence of allergic airways disease on the immune response to respiratory Streptococcus pneumoniae infection', 5th International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs (2006) [E3]
2006Horvat JC, Moller CG, Wade MA, Preston JA, Hansbro NG, Gibson PG, et al., 'The development of allergic airways disease (AAD) is differently affected by chlamydial lung infection at different stages of life', Immunology and Cell Biology, Auckland, NZ (2006) [E3]
2006Horvat JC, Preston JA, Gibson PG, Beagley KW, Foster PS, Hansbro PM, 'Exacerbation of Allergic Airways Disease (AAD) by Chlamydia is Differentially Affected by the Timing of Infection Relative to Allergen Exposure', Immunology and Cell Biology, Auckland, NZ (2006) [E3]
2006Mattes J, Simpson JL, Foster PS, Gibson PG, 'Trail is upregulated in the airways of asthmatics', Respirology, Canberra (2006) [E3]
2006Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory Streptococcus pneumoniae infection decreases key inflammatory responses in a mouse model of asthma', Abstracts ATS 2006 International Conference, San Diego, California (2006) [E3]
2006Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Streptococcus pneumoniae (SPN) lung infection suppresses hallmark features of a mouse model of asthma', Immunology and Cell Biology, Auckland, NZ (2006) [E3]
2006Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Inhibition of allergic lung disease by respiratory streptococcus pneumoniae infection', Respirology, Canberra (2006) [E3]
2006Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Inhibition of allergic lung disease by respiratory Streptococcus pneumoniae infection', 5th International Symposium on Pneumococci and Pneumococcal Diseases, Alice Springs (2006) [E3]
2006Kaiko GE, Phipps S, Lam CE, Hickey DK, Hansbro NG, Foster PS, Beagley KW, 'The chlamydia infection of dendritic cells drives the development of a pro-asthmatic response', Immunology and Cell Biology, Auckland, NZ (2006) [E3]

Co-authors: Nicole Hansbro

2006Horvat JC, Wade MA, Preston JA, Hansbro NG, Gibson PG, Beagley KW, et al., 'Neonatal chlamydial infection exacerbates allergic airways disease', Abstracts ATS 2006 International Conference, San Diego, California (2006) [E3]
2006Dixon CM, Christie J, Matthaei KI, Foster PS, Webb DC, 'Identification & characterisation of proteins associated with allergic airways disease (AAD)', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Miami Beach, FL (2006)
2006Forbes EE, Matthaei KI, Newhouse MJ, Foster PS, Hogan SP, 'Gastrointestinal allergic inflammation: IL-9, mast cells and intestinal anaphylaxis', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, Miami Beach, FL (2006)
2005Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory Streptococcus Pneumoniae Infection Decreases Eosinophilia and Mucus Cell Hyperplasia in a Mouse Model of Asthma', Respirology, Perth Convention Exhibition Centre (2005) [E3]
2005Horvat JC, Wade MA, Preston JA, Newcombe N, Ferguson AL, Kaiko G, et al., 'Neonatal But Not Adult Chlamydial Infection Induces the Development of Allergic Airways Disease Through Novel Mechanisms Involving Inflammation of Mixed Phenotype', Tissue Antigens, Melbourne, Australia (2005) [E3]
2005Horvat JC, Preston JA, Hansbro NG, Ferguson AL, Gibson PG, Beagley KW, et al., 'Neonatal chlamydial infection inhibits the development of allergic airway inflammation in adult mice', Inflammation Research, Melbourne, Australia (2005) [E3]
2005Phipps S, Lam E, Newhouse M, Mahalingam S, Foster PS, Matthaei KI, 'Eosinophils Contribute to Antiviral Immunity Through the Expression of TLR7', 'Genetics and The Immune Response' Abstracts of the 35th Annual Scientific Meeting of the Australasian Society for Immunology and 14th International HLA & Immunogenetics Workshop, Melbourne (2005) [E3]
2005Preston JA, Horvat JC, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Timing of Streptococcus Pneumoniae (pnc) infection determines the magnitute of the effect on allergic airways inflammation (AAI) in a mouse model of asthma', Respirology, Perth Convention Exhibition Centre (2005) [E3]
2005Preston JA, Horvat JC, Wade MA, Beagley KW, Foster PS, Gibson PG, Hansbro PM, 'Respiratory streptococcus pneumoniae infection decreases key inflammatory responses in a mouse model of asthma', TISSUE ANTIGENS, Melbourne, AUSTRALIA (2005)
2001Mahalingam S, Karupiah G, Takeda K, Akira S, Matthaei K, Foster PS, 'Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus', Proceedings of the National Academy of Sciences of the United States of America, . (2001) [E1]
2000Simson L, Foster PS, 'Chemokine and cytokine cooperativity: Eosinophil migration in the asthmatic response', Immunology and Cell Biology, . (2000) [E1]
2000Hogan S, Mishra A, Brandt E, Foster PS, Rothenberg M, 'A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy', Proceedings of the National Academy of Sciences of the United States of America, . (2000) [E1]
1998Hogan S, Foster PS, Charlton B, Slattery R, 'Prevention of Th2-mediated murine allergic airways disease by soluble antigen administration in the neonate', Proceedings of the National Academy of Sciences of the United States of America, . (1998) [E1]
1998Hogan S, Mould A, Young J, Rothenberg M, Ramsay A, Matthaei K, et al., 'Cellular and molecular regulation of eosinophil trafficking to the lung', Immunology and Cell Biology, . (1998) [E1]
Show 102 more
Edit

Grants and Funding

Summary

Number of grants85
Total funding$19,386,566

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2014 (9 grants)

Characterising the immune function of a newly discovered CD4 T helper cell (Th22) and understanding its role in allergic inflammation$690,558
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$690,55820142016
GNo:G1300109

New way of treating respiratory infections and airway inflammatory diseases by targeting miRNA $677,562
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Doctor Ming Yang
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$677,56220142016
GNo:G1300121

Toll-like receptor 7 and asthma $673,712
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Joerg Mattes, Professor Paul Foster, Conjoint Professor Peter Wark
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$673,71220142016
GNo:G1300093

How resident host defence cells contribute to the development of childhood asthma and severe attacks of asthma $587,562
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Rakesh Kumar
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$587,56220142016
GNo:G1300100

Expanding the Genomic Frontier - from Species to Strains and Individuals to Populations$150,000
Funding Body: University of Newcastle

Project Team
Professor Marc Wilkins, Professor Rick Cavicchioli, Professor Brett Neilan, Professor Rodney Scott, Professor Paul Foster, Associate Professor Phillip Dickson, Professor Ian Charles, Associate Professor Elizabeth Harry, Associate Professor Steven Djordjevic, Associate Professor Cynthia Whitchurch, Professor Ian Paulsen, Professor Nicolle Packer, Professor Michael Gillings
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$150,00020142014
GNo:G1300426

Expanding the Genomic Frontier - from Species to Strains and Individuals to Populations$128,147
Funding Body: ARC (Australian Research Council)

Project Team
Professor Marc Wilkins, Professor Rick Cavicchioli, Professor Brett Neilan, Professor Rodney Scott, Professor Paul Foster, Associate Professor Phillip Dickson, Professor Ian Paulsen, Professor Nicolle Packer, Professor Michael Gillings, Professor Ian Charles, Associate Professor Elizabeth Harry, Associate Professor Steven Djordjevic, Associate Professor Cynthia Whitchurch
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Investigator
Total AmountFunding StartFunding Finish
$128,14720142014
GNo:G1301339

The Nanostring nCounter System$75,000
Funding Body: Ramaciotti Foundations

Project Team
Professor Darryl Knight, Professor Phil Hansbro, Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
SchemeRole
Major Equipment AwardInvestigator
Total AmountFunding StartFunding Finish
$75,00020142014
GNo:G1300853

The Nanostring nCounter System$40,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Darryl Knight, Professor Phil Hansbro, Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$40,00020142014
GNo:G1301083

The Nanostring nCounter System$20,000
Funding Body: John Hunter Hospital Charitable Trust Fund

Project Team
Professor Darryl Knight, Professor Phil Hansbro, Professor Paul Foster, Professor Rodney Scott, Conjoint Professor Peter Gibson, Professor Michael Nilsson
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020142014
GNo:G1301084

2013 (4 grants)

HMRI MRSP Infrastructure (12-16) - VIVA Program$973,342
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson
SchemeRole
NSW MRSP Infrastructure GrantChief Investigator
Total AmountFunding StartFunding Finish
$973,34220132016
GNo:G1300567

Molecular and cellular characterisation of TLR7 signalling in rhinovirus-induced asthma exacerbation$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Joerg Mattes, Professor Paul Foster
SchemeRole
Near MissInvestigator
Total AmountFunding StartFunding Finish
$25,00020132013
GNo:G1300692

DP73 Digital colour and monochrome camera + cellSens software + Xcite120 fluorescence lamp illuminator$20,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Doctor Alan Hsu, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Katie Baines, Associate Professor Jodie Simpson, Professor Rakesh Kumar, Doctor Nicole Hansbro, Doctor Steven Maltby, Doctor Ming Yang, Doctor Gerard Kaiko, Doctor Jay Horvat, Doctor Simon Keely, Doctor Andrew Jarnicki, Doctor Michael Fricker
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020132013
GNo:G1201186

American Academy of Allergy Asthma & Immunology Annual Meeting, Henry B Gonzalez Convention Centre, San Antonio USA, 22 - 26 February 2013$2,000
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Paul Foster
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,00020132013
GNo:G1300349

2012 (11 grants)

Targeting miRNA to inhibit leukocyte differentiation: a novel anti-inflammatory approach for the treatment of asthma$590,886
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Ian Young
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$590,88620122014
GNo:G1100129

Understanding the mechanisms of steroid resistant inflammatory pathways in mouse models of asthma: potential new treatment approaches$514,551
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Doctor Ming Yang
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$514,55120122014
GNo:G1100099

HMRI MRSP Infrastructure (11-12)- VIVA$486,671
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson
SchemeRole
NSW MRSP Infrastructure GrantChief Investigator
Total AmountFunding StartFunding Finish
$486,67120122012
GNo:G1101137

BD FACSAria III Cell Sorter: 3 laser 10-colour Flow Cytometer$180,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson, Laureate Professor John Aitken, Professor Roger Smith, Professor Rodney Scott
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Chief Investigator
Total AmountFunding StartFunding Finish
$180,00020122012
GNo:G1100746

BD FACSAria III Cell Sorter: 3 laser 10-colour Flow Cytometer$150,000
Funding Body: University of Newcastle

Project Team
Professor Paul Foster, Professor Trevor Day, Conjoint Professor Peter Gibson, Laureate Professor John Aitken, Professor Roger Smith, Professor Rodney Scott
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$150,00020122012
GNo:G1100744

BD FACSAria III Cell Sorter: 3 laser 10-colour Flow Cytometer$122,927
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson, Laureate Professor John Aitken, Professor Roger Smith, Professor Rodney Scott
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$122,92720122012
GNo:G1200668

SpectraMax M5e Multi-Mode Microplate Reader$50,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Professor Rakesh Kumar, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Jay Horvat, Doctor Simon Keely, Doctor Andrew Jarnicki, Doctor Linda Howland, Doctor Kelly Asquith
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$50,00020122012
GNo:G1100975

Australia-Harvard Fellowship$36,000
Funding Body: Harvard Club of Australia Foundation

Project Team
Professor Paul Foster
SchemeRole
Australia-Harvard Fellowships Chief Investigator
Total AmountFunding StartFunding Finish
$36,00020122012
GNo:G1200214

Australia-Harvard Fellowship - Allen$26,000
Funding Body: Harvard Club of Australia Foundation

Project Team
Professor Paul Foster
SchemeRole
Australia-Harvard Fellowships Chief Investigator
Total AmountFunding StartFunding Finish
$26,00020122012
GNo:G1200238

Elucidating the mechanisms of steroid-resistant asthma$15,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Jay Horvat, Professor Phil Hansbro, Professor Paul Foster
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$15,00020122012
GNo:G1200190

American Academy of Allergy Asthma and Immunology Annual Meeting 2012, Orlando, Florida, 2 - 6 March 2012$2,000
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Paul Foster
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,00020122012
GNo:G1200407

2011 (11 grants)

Targeting microRNA (miRNA) as a unified therapeutic approach to the treatment of asthma and allergic inflammation$651,732
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Joerg Mattes, Professor Rakesh Kumar
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$651,73220112013
GNo:G1000262

Mast cell proteases suppress respiratory viral infections and allergic inflammation of the airways$642,561
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Dr Michele Grimbaldeston
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$642,56120112013
GNo:G1000260

Establishment of a comprehensive regional biophysical analysis facility $500,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Peter Lewis, Professor Nicholas Dixon, Professor Eileen McLaughlin, Professor Adam McCluskey, Associate Professor Aaron Oakley, Professor Paul Foster, Laureate Professor John Aitken, Associate Professor Jennifer Beck, Dr Michael Kelso, Professor Graham Nicholson, Associate Professor Elizabeth Harry, Professor Ian Charles, Associate Professor Steven Djordjevic
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Investigator
Total AmountFunding StartFunding Finish
$500,00020112011
GNo:G1000630

HMRI MRSP Infrastructure Grant (10-11) VIVA$485,452
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Peter Gibson, Professor Paul Foster
SchemeRole
NSW MRSP Infrastructure GrantInvestigator
Total AmountFunding StartFunding Finish
$485,45220112011
GNo:G1100162

Development of microbial bioproducts for the suppression of inflammation$285,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Phil Hansbro, Professor Paul Foster, Professor Rakesh Kumar
SchemeRole
Discovery ProjectsInvestigator
Total AmountFunding StartFunding Finish
$285,00020112013
GNo:G1000021

Establishment of a comprehensive regional biophysical analysis facility $230,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Peter Lewis, Professor Nicholas Dixon, Professor Eileen McLaughlin, Professor Adam McCluskey, Associate Professor Aaron Oakley, Professor Paul Foster, Laureate Professor John Aitken, Associate Professor Jennifer Beck, Dr Michael Kelso, Professor Graham Nicholson, Associate Professor Elizabeth Harry, Professor Ian Charles, Associate Professor Steven Djordjevic
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF) Partner fundingInvestigator
Total AmountFunding StartFunding Finish
$230,00020112011
GNo:G1100484

DVCR Special Grant 2011$140,000
Funding Body: University of Newcastle

Project Team
Professor Paul Foster
SchemeRole
Special Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$140,00020112011
GNo:G1101011

Research microscope, confocal ready nikon eclipse 90i microscope$69,157
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Roger Smith, Conjoint Professor Tam Zakar, Associate Professor Jon Hirst, Doctor Kaushik Maiti, Doctor Gemma Madsen, Professor Rodney Scott, Conjoint Professor Peter Wark, Professor Paul Foster, Professor Phil Hansbro, Conjoint Professor Ian Wright
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$69,15720112011
GNo:G1100024

Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000
Funding Body: Maitland Cancer Appeal Committee

Project Team
Professor Phil Hansbro, Professor Paul Foster, Doctor Gough Au
SchemeRole
Research Project Investigator
Total AmountFunding StartFunding Finish
$50,00020112011
GNo:G1100246

SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Phil Hansbro, Professor Paul Foster, Professor Joerg Mattes, Doctor Simon Keely, Doctor Jay Horvat, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Catherine Ptaschinski, Doctor Kelly Asquith, Doctor Gough Au, Conjoint Professor Peter Wark, Laureate Professor John Aitken, Conjoint Professor Keith Jones, Professor Roger Smith, Professor Judith Black, Professor Rakesh Kumar, Professor Paul Hertzog
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$45,00020112011
GNo:G1100037

Sparke Helmore/NBN Triathlon Award for Research Excellence$15,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster
SchemeRole
Sparke Helmore/NBN Television Corporate Triathlon Award for Research ExcellenceChief Investigator
Total AmountFunding StartFunding Finish
$15,00020112011
GNo:G1000985

2010 (8 grants)

The role of microRNAs in the regulation of antiviral and inflammatory responses during experimental rhinovirus infection$583,500
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Joerg Mattes, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$583,50020102012
GNo:G0190183

HMRI MRSP Infrastructure Grant (09-10) - VIVA$397,696
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson
SchemeRole
NSW MRSP Infrastructure GrantChief Investigator
Total AmountFunding StartFunding Finish
$397,69620102010
GNo:G1000232

Laser microdissection microscopy system for cell and development biology$350,000
Funding Body: ARC (Australian Research Council)

Mechanisms of induction and progression of childhood asthma: investigations in a mouse model $240,750
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Rakesh Kumar, Professor Paul Foster, Dr Megan Hitchins
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$240,75020102012
GNo:G0900216

Laser microdissection microscopy system for cell and development biology$215,000
Funding Body: University of Newcastle

Buxco FinePointe software and FinePointe RC system for mice $39,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Nicole Hansbro, Doctor Simon Phipps, Doctor Ming Yang, Doctor Kelly Asquith, Doctor Catherine Ptaschinski, Professor Rakesh Kumar, Professor Judith Black
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$39,00020102010
GNo:G1000053

Molecular markers of reversible airway obstruction in early life and correlation with clinical wheezing patterns$19,842
Funding Body: Hunter Children`s Research Foundation

Project Team
Professor Joerg Mattes, Professor Paul Foster, Conjoint Associate Professor Bruce Whitehead, Doctor Ana Pereira De Siqueira
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$19,84220102010
GNo:G0900119

The 8th Asia Pacific Congress of Allergy, Asthma and Clinical Immunology, Singapore, 6 - 9 November 2010$2,000
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Paul Foster
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,00020102010
GNo:G1000937

2009 (5 grants)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$495,000
Funding Body: ARC (Australian Research Council)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$50,000
Funding Body: ARC (Australian Research Council)

Coulter counter$41,150
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Simon Phipps, Doctor Ming Yang, Doctor Nicole Hansbro, Doctor Kelly Asquith
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$41,15020092009
GNo:G0189851

Development of novel therapeutic approaches for rhinovirus - induced asthma exacerbation$24,500
Funding Body: Hunter Medical Research Institute

Project Team
Professor Joerg Mattes, Professor Paul Foster, Conjoint Professor Peter Wark
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$24,50020092009
GNo:G0189800

Immunisation against chlamydia-associated asthma$20,000
Funding Body: Rebecca L Cooper Medical Research Foundation Ltd

Project Team
Doctor Jay Horvat, Professor Phil Hansbro, Professor Paul Foster
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020092009
GNo:G0189629

2008 (7 grants)

The role of microRNAs as new anti-inflammatory targets for the treatment of asthma$600,375
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Rakesh Kumar, Assoc. Prof Klaus Matthaei, Professor Joerg Mattes
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$600,37520082010
GNo:G0187584

Targeting the shared beta-chain of the IL-3, IL-5 and GM-CSF receptors as therapy for allergic inflammation$585,375
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Angel Lopez
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$585,37520082010
GNo:G0187585

The mechanisms underlying pneumoviral-induced angiogenesis of the lung and its impact on the asthmatic response$541,875
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Judith Black
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$541,87520082010
GNo:G0187591

Role of IL-3 in allergic inflammation: modulation of basophils, mast cells, eosinophils and remodelling in asthma$235,050
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$235,05020082010
GNo:G0189190

Individually ventilated cages (IVC) and associated ventilator, holding boxes and water bottles$35,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Simon Phipps, Doctor Ming Yang, Doctor Nicole Hansbro, Doctor Kelly Asquith
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$35,00020082008
GNo:G0188541

MicroRNA and antagomirs in the regulation and suppression of interferon (IFN)-g and lipopolysaccharide (LPS) induced steroid-resistant airways hyperreactivity$24,250
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Ming Yang, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$24,25020082008
GNo:G0188474

Therapeutic potential of targeting the IL-3/IL-5/GM-CSF common beta receptor to treat allergic inflammation and asthma$23,957
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Asquith, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$23,95720082008
GNo:G0188460

2007 (9 grants)

HMRI - Viruses, Infection/Immunity, Vaccines and Asthma Research Program$692,213
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson, Conjoint Professor Stephen Graves, Associate Professor Darren Shafren
SchemeRole
NSW MRSP Infrastructure GrantChief Investigator
Total AmountFunding StartFunding Finish
$692,21320072009
GNo:G0187930

Influence of early-life viral infection on severity of murine chronic asthma and acute exacerbations$231,750
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Rakesh Kumar
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$231,75020072009
GNo:G0187409

Differential regulation of human mast cell degranulation by discrete forms of protein phosphatase 2A$50,000
Funding Body: Asthma Foundation of New South Wales

Project Team
Professor Alistair Sim, Doctor Nikki Verrills, Professor Paul Foster, Conjoint Professor Peter Wark, Conjoint Professor Peter Gibson, Dr Gregory Kranias
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$50,00020072007
GNo:G0187247

Nitric Oxide Monitoring System (NIOX)$45,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Peter Gibson, Conjoint Associate Professor Vicki Clifton, Conjoint Professor Warwick Giles, Emeritus Professor Michael Hensley, Doctor Vanessa Murphy, Conjoint Professor Peter Wark, Associate Professor Vanessa McDonald, Associate Professor Jodie Simpson, Conjoint Associate Professor Bruce Whitehead, Professor Paul Foster, Professor Phil Hansbro, Associate Professor Lisa Wood
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$45,00020072007
GNo:G0188193

Class II biohazard containment hood and carbon dioxide cell culture incubator$20,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Peter Wark, Conjoint Professor Peter Gibson, Associate Professor Jodie Simpson, Doctor Vanessa Murphy, Associate Professor Lisa Wood, Professor Paul Foster, Professor Phil Hansbro
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0188192

Elucidation of the association between Haemophilus influenzae infection and neutrophilic asthma.$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Phil Hansbro, Associate Professor Jodie Simpson, Professor Paul Foster, Conjoint Professor Margaret Dunkley
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0187206

Hewlett Packard 7890 series gas chromatograph with accessories$20,000
Funding Body: NHMRC (National Health & Medical Research Council)

The role of tumstatin in angiogenesis and asthma$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Paul Foster, Doctor Nicole Hansbro, Doctor Simon Phipps, Professor Phil Hansbro
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0187238

The prevention and treatment of Asthma with a diet high in seafood content$15,525
Funding Body: Seafood Services Australia

Project Team
Professor Phil Hansbro, Professor Paul Foster
SchemeRole
Seafood Industry Development FundInvestigator
Total AmountFunding StartFunding Finish
$15,52520072007
GNo:G0185404

2006 (8 grants)

PRC Priority Research Centre for Asthma & Respiratory Diseases$524,282
Funding Body: University of Newcastle

Project Team
Professor Paul Foster, Conjoint Professor Peter Gibson, Conjoint Professor Kenneth Beagley, Emeritus Professor Michael Hensley, Professor Phil Hansbro, Professor Joerg Mattes, Professor Alistair Sim, Conjoint Professor Peter Wark
SchemeRole
Priority Research CentreChief Investigator
Total AmountFunding StartFunding Finish
$524,28220062013
GNo:G0186914

Surveillance and Analysis of Avian Influenza Viruses in Migratory Birds in Australia$249,625
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Phil Hansbro, Dr Ian Barr, Conjoint Professor Peter Wark, Dr Paul Selleck, Dr Simone Warner, Professor Paul Foster, Dr Aeron Hurt, Dr Irene Peroulis, Dr John Curran, Conjoint Professor Peter Gibson
SchemeRole
Potential Avian Influenza-Induced PandemicInvestigator
Total AmountFunding StartFunding Finish
$249,62520062006
GNo:G0186000

Targeting protein phosphatases to control mast cell activation$50,000
Funding Body: Asthma Foundation of New South Wales

Project Team
Professor Alistair Sim, Professor Paul Foster
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$50,00020062006
GNo:G0186027

CD4+T-cell programming in early life and neonatal infection.$25,000
Funding Body: GlaxoSmithKline Australia

Project Team
Professor Paul Foster, Ms Angela Ferguson
SchemeRole
Support GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020062007
GNo:G0186837

Identification of early-life signals induced in response to infection that predispose to asthma in later life$20,000
Funding Body: University of Newcastle

Project Team
Professor Phil Hansbro, Professor Paul Foster, Conjoint Professor Kenneth Beagley, Professor Alistair Sim
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020062006
GNo:G0186699

CD4 T Cell Programming by early life and neonatal infection$18,837
Funding Body: Asthma Foundation of New South Wales

Project Team
Ms Angela Ferguson, Professor Paul Foster
SchemeRole
PhD ScholarshipsInvestigator
Total AmountFunding StartFunding Finish
$18,83720062006
GNo:G0186002

Role of TRAIL on development of atopic dermatitis and T helper type 2 immunity$16,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Joerg Mattes, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$16,00020062006
GNo:G0186098

CRC for asthma - shared with Monash University$15,000
Funding Body: CRC for Asthma

Project Team
Professor Paul Foster
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$15,00020062006
GNo:G0186654

2005 (7 grants)

Drug targets from new animal models$2,030,948
Funding Body: CRC for Asthma

Project Team
Professor Paul Foster, Professor Phil Hansbro, Professor Joerg Mattes, Doctor Ming Yang, Dr Simon Phipps
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,030,94820052011
GNo:G0185860

CD4 T cell programming by neonatal and early-life infection$250,000
Funding Body: ARC (Australian Research Council)

Project Team
Professor Paul Foster, Conjoint Professor Kenneth Beagley, Professor Phil Hansbro
SchemeRole
Discovery ProjectsChief Investigator
Total AmountFunding StartFunding Finish
$250,00020052007
GNo:G0184398

High throughput proteomics - Thermo Finnigan ProteomeX LCQ Integrated Proteomicis Workstation$207,189
Funding Body: ARC (Australian Research Council)

Modulation of inflammatory responses in the asthmatic lung by Chlamydial infection$50,000
Funding Body: Asthma Foundation of New South Wales

Project Team
Professor Phil Hansbro, Professor Paul Foster, Conjoint Professor Kenneth Beagley
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$50,00020052005
GNo:G0185208

SealSafe Shelving Module IVC System & Slimline AHU Air Control Mobile Trolley$41,449
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster
SchemeRole
Equipment GrantChief Investigator
Total AmountFunding StartFunding Finish
$41,44920052005
GNo:G0185470

Chlamydia infection of dendritic cells drives the development of pro-asthmatic Th2 cells$15,000
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Professor Kenneth Beagley, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$15,00020052005
GNo:G0184898

Prevention of asthma by immunisation with pneumococcal cell walls$10,000
Funding Body: University of Newcastle

Project Team
Professor Phil Hansbro, Professor Paul Foster, Conjoint Professor Kenneth Beagley, Conjoint Professor Peter Gibson
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020052005
GNo:G0184712

2004 (6 grants)

Molecular Mechanisms in the Regulation of allergy and inflammation$663,608
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Dr Simon Hogan, Assoc. Prof Klaus Matthaei, Professor Philip Thompson, Professor Ian Young
SchemeRole
Program GrantChief Investigator
Total AmountFunding StartFunding Finish
$663,60820042007
GNo:G0184188

Cytokines regulating airway inflammation, remodelling and hyper-reactivity in chronic asthma$110,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Paul Foster, Professor Rakesh Kumar, Dr Mark Raftery
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$110,00020042006
GNo:G0184155

Modulation of Asthma by bacterial infection or vaccination in different age groups$60,000
Funding Body: Rebecca L Cooper Medical Research Foundation Ltd

Project Team
Professor Phil Hansbro, Professor Paul Foster, Conjoint Professor Kenneth Beagley
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$60,00020042006
GNo:G0184154

Investigation of the role of eosinophils in regulating disease processes in asthma$15,000
Funding Body: University of Newcastle

Project Team
Professor Paul Foster
SchemeRole
New Staff GrantChief Investigator
Total AmountFunding StartFunding Finish
$15,00020042004
GNo:G0184841

Modulation of immune responses in asthma by bacterial infections during early life.$15,000
Funding Body: University of Newcastle

Project Team
Professor Phil Hansbro, Professor Paul Foster, Conjoint Professor Peter Gibson
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$15,00020042004
GNo:G0183512

Chemokine-mediated enhancement of transcutaneous immunization to target genital and respiratory tract chlamydial infections$10,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Kenneth Beagley, Professor Paul Foster
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020042004
GNo:G0183467
Edit

Research Supervision

Number of current supervisions22
Total current UoN Masters EFTSL0.1
Total current UoN PhD EFTSL3.75

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20142018PhD (Immunology & Microbiol)Co-SupervisorChronic Obstructive Pulmonary Disease (COPD)
20132015M Philosophy (Immun & Microbi)Co-SupervisorRole of Innate Immune Cells in the Pathogenesis of COPD
20132017PhD (Immunology & Microbiol)Co-SupervisorRole of TLR/IL-13/STAT6/PI3K Response in Early-life Respiratory Infection and Infection-Induced Chronic Lung Disease
20132017PhD (Paediatrics)Co-SupervisorThe Role of MicroRNAs in Response to Rhinovirus Infection in Allergic Airways Disease
20132017PhD (Immunology & Microbiol)Co-SupervisorInvestigation of the pathogenesis and potential therapeutic interventions of influenza in Asthma and COPD
20122016PhD (Immunology & Microbiol)Co-SupervisorInvestigating the Mechanisms of Tobacco Cigarette Smoke-Induced Lung Cancer
20122016PhD (Immunology & Microbiol)Co-SupervisorThe Role of Rhinovirus, TRAIL, IL-13 and PP2A in Allergic Airways Disease
20122016PhD (Immunology & Microbiol)Co-SupervisorUnderstanding the mechanisms of airway hyper-responsiveness in a mouse model of asthma
20122016PhD (Immunology & Microbiol)Co-SupervisorRoles of Bromodomain and extra terminal (BET) proteins in Suppression of Airway Inflammation
20122016PhD (Immunology & Microbiol)Co-SupervisorAssessing the Epigenetic Involvement in the Development and Progression of Chronic Obstructive Pulmonary Disease (COPD)
20122016PhD (Paediatrics)Co-SupervisorThe Role of TRAIL in the Induction and Perpetuation of Eosinophilic Oesophagitis
20112015PhD (Immunology & Microbiol)Co-SupervisorMechanisms of Predisposition to Secondary Bacterial Pneumonia
20112015PhD (Immunology & Microbiol)Co-SupervisorThe Role of Interferon Epsilon in Protection Against Chlamydial Reproductive Tract Infections
20112015PhD (Immunology & Microbiol)Co-SupervisorThe Roles of Fibulin-1 in Airway Remodelling in Lung Diseases
20112015PhD (Immunology & Microbiol)Co-SupervisorThe Role of Innate Cells in Infectious Exacerbation of COPD
20112015PhD (Immunology & Microbiol)Co-SupervisorInvestigation of Pathogenesis of Chronic Obstructive Pulmonary Disease (COPD)
20112015PhD (Immunology & Microbiol)Co-SupervisorImmunoregulatory Therapies for Inflammatory Diseases
20102015PhD (Immunology & Microbiol)Co-SupervisorIndentification of New Therapeutics in COPD/ Emphysema
20102014PhD (Immunology & Microbiol)Co-SupervisorRole of TRAIL and TLRT in Response to Rhinovirus Infection in Allergic Airways Disease
20092013PhD (Immunology & Microbiol)Co-SupervisorMechanisms of Increased Susceptibility to Influenza Infection in Chronic Airways Disease Mouse Models
20082012PhD (Immunology & Microbiol)Principal SupervisorThe Role of microRNAs in Allergic Airways Disease and T Cell Biology
20072011PhD (Immunology & Microbiol)Co-SupervisorInvestigation of the Mechanisms of Respiratory Infection- Induced Lung Disease

Past Supervision

YearProgramSupervisor TypeResearch Title
2014PhD (Immunology & Microbiol)Co-SupervisorImmune Mechanisms that Underpin Early-Life Chlamydia Respiratory Infection-Induced Chronic Lung Disease
2014PhD (Immunology & Microbiol)Principal SupervisorThe Role of MicroRNA in Regulating Anti-Bacterial Responses in Innate Immune Cells
2014PhD (Immunology & Microbiol)Co-SupervisorRespiratory Innate Immune Factors Regulate Steroid-resistant Airway Hyperreactivity and Asthma
2013PhD (Immunology & Microbiol)Principal SupervisorThe Role of Early Life Infection on the Programming of CD4+ T-cells
2012PhD (Immunology & Microbiol)Co-SupervisorModulation of Responses in Allergic Airways Disease by Haemophilus Influenzae Infection
2012PhD (Immunology & Microbiol)Co-SupervisorNovel Therapeutic Approaches for the Treatment of Allergic Airways Disease
2011PhD (Immunology & Microbiol)Principal SupervisorUnderstanding the Inflammatory Mechanisms That Predispose to Emphysema in Mouse Models
2011PhD (Immunology & Microbiol)Principal SupervisorImmune Mechanisms that Promote the Development of Inducible Bronchus-Associated Lymphoid Tissue (IBALT)
2011PhD (Immunology & Microbiol)Principal SupervisorThe Innate Immune Mechanisms Underlying the Interplay Between Respiratory Infections and Asthma
2009PhD (Immunology & Microbiol)Principal SupervisorNutritional Modulation of Lung Inflammation
2008PhD (Immunology & Microbiol)Co-SupervisorModulation of Responses in the Asthmatic Lung by Chlamydial Infection
2007PhD (Immunology & Microbiol)Co-SupervisorModulation of Responses in the Asthmatic Lung by Streptococcus Pneumoniae
Edit

Professor Paul Foster

Work Phone(02) 4042 0163
Fax(02) 4042 0036
Email
PositionLaureate Professor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaImmunology and Microbiology
Office
2401 HMRI,
HMRI,
Other
URL:www.newcastle.edu.au/profile/paul-foster